Degenerative macular diseases

MACULA_NAS

macular degeneration: Loss of vision in the central portion of the retina (macula), secondary to retinal degeneration. [ NCIT:P378 ]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H35.39# Cause of death: ICD-10 — H35.39# 2 out of 7 registries used, show all original rules.	5814
4. Check minimum number of events None	5814
5. Include endpoints None	5814
6. Filter based on genotype QC (FinnGen only)	5209

Control definitions (FinnGen only)

Control exclude: H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H35
Name in latin: Striae angioides maculae

NAME	MACULA_NAS
CONTROL_EXCLUDE	H7_CHOROIDRETINA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H3539
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H3539
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Degenerative macular diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Degenerative macular diseases, drug-induced

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	33887	19783	14000
Only index persons	32124	18934	13190
Unadjusted period prevalence (%)
Whole population	0.49	0.57	0.39
Only index persons	0.62	0.70	0.50
Median age at first event (years)
Whole population	70.47	70.87	69.89
Only index persons	70.16	70.58	69.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5209	2846	2363
Unadjusted period prevalence (%)	1.04	1.01	1.08
Median age at first event (years)	68.76	67.72	70.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5355: Matched controls
53550

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

CKD40

NOMESCO Finland

Endophotocoagulation of retina

823.6

319.1

311

H35.37

ICD-10 Finland

Macular holes

1422.9

307.7

515

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

214.2

307.7

952

XCW99

NOMESCO Finland

Other investigative procedure of eye

10.4

307.7

1783

2463

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

283.8

307.7

582

S01BC05

ATC

ketorolac; ophthalmic

6.5

307.7

664

1141

H25.1

ICD-10 Finland

Senile nuclear cataract

3.1

307.7

2815

14189

CKC12

NOMESCO Finland

Photocoagulation of retina

73.0

307.7

380

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.4

307.7

1751

5313

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

117.4

307.7

289

H26.4

ICD-10 Finland

After-cataract

4.7

307.7

1481

4040

H33.0

ICD-10 Finland

Retinal detachment with retinal break

783.0

307.7

433

H34.8

ICD-10 Finland

Other retinal vascular occlusions

115.0

307.7

210

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

308.4

307.7

1103

XCD20

NOMESCO Finland

Photoangiography of eye

94.2

307.7

385

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

209.1

307.7

1085

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

10.8

307.7

985

1099

H35.9

ICD-10 Finland

Retinal disorder, unspecified

120.6

307.7

175

CJB10

NOMESCO Finland

Laser discission of secondary cataract

5.1

307.7

1308

3197

WX140

NOMESCO Finland

Parabulbar anesthesy

25.1

307.7

1155

580

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

533.2

307.7

696

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

4.0

307.7

3457

16833

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

11.0

307.7

1492

1816

Z96.1

ICD-10 Finland

Presence of intraocular lens

6.2

307.7

2159

5224

S01BC03

ATC

diclofenac; ophthalmic

9.8

307.7

392

426

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

43.5

307.7

968

270

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

128.8

307.7

910

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

152.2

307.7

205

XCK10

NOMESCO Finland

Photography of fundus of eye

6.3

307.7

1240

2459

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

2616.3

307.7

922

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

4503599627370496.0

307.7

5354

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

4.0

307.7

3216

14579

CKC10

NOMESCO Finland

Local photocoagulation of retina

122.3

307.7

234

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

115.0

307.7

453

H33.3

ICD-10 Finland

Retinal breaks without detachment

281.0

307.7

267

S01ED51

ATC

timolol, combinations; ophthalmic

4.1

292.7

928

2604

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

107.9

286.2

147

H35.7

ICD-10 Finland

Separation of retinal layers

+∞

277.5

264

H35.36

ICD-10 Finland

Macular cyst

1403.5

275.2

266

H26.2

ICD-10 Finland

Complicated cataract

16.6

268.4

227

142

H43.1

ICD-10 Finland

Vitreous haemorrhage

12.5

252.5

252

211

H36.01

ICD-10 Finland

Diabetic maculopathy

108.4

247.3

127

XCH00

NOMESCO Finland

Eye pressure measurement

5.1

227.5

511

1085

XCK00

NOMESCO Finland

Perimetry

3.8

188.1

638

1850

CKC15

NOMESCO Finland

Panretinal photocoagulation

98.8

186.8

H20.1

ICD-10 Finland

Chronic iridocyclitis

13.8

180.4

168

125

H3601, E113,

ICD-10 Finland

+∞

180.2

172

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

169.7

2926

18936

S01EC01

ATC

acetazolamide; systemic

6.5

166.7

280

451

H36.00

ICD-10 Finland

Diabetic background retinopathy

47.3

159.0

H35.8

ICD-10 Finland

Other specified retinal disorders

383.0

149.8

150

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

76.1

139.5

S01ED01

ATC

timolol; ophthalmic

4.1

137.5

406

1061

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

4.6

136.3

336

765

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

12.6

136.3

134

109

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

59.3

135.8

ZXA10

NOMESCO Finland

Bilateral

2.3

132.9

1321

6721

ZX198

NOMESCO Finland

Other local administration

15.6

132.6

115

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

14.9

131.6

117

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

13.2

130.8

125

XCD10

NOMESCO Finland

Electrophysiological examination of eye

5.7

128.8

247

452

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

9.8

126.9

148

155

S01EA05

ATC

brimonidine; ophthalmic

4.7

126.4

307

690

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

7.9

126.3

175

228

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

1215.9

122.4

119

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

601.4

119.6

118

ZXA05

NOMESCO Finland

Left side

2.0

117.2

1675

9740

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.3

113.6

1095

5460

H3600, E113,

ICD-10 Finland

+∞

110.8

106

114

Kela drug reimbursment

Glaucoma

2.5

110.5

800

3514

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

10.2

109.9

124

S01EE01

ATC

latanoprost; ophthalmic

2.8

109.3

608

2343

H3603, E113,

ICD-10 Finland

+∞

107.7

103

H25.8

ICD-10 Finland

Other senile cataract

2.3

106.4

991

4859

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

38.7

105.9

ZXA00

NOMESCO Finland

Right side

1.9

103.6

1751

10707

CKD20

NOMESCO Finland

Removal of vitreous body substitute

517.8

103.0

102

XCW10

NOMESCO Finland

Assessment of vision

6.6

102.4

166

257

WX142

NOMESCO Finland

Sub-tenon anesthesy

13.2

101.6

H26.02

ICD-10 Finland

Presenil cataract

4.8

99.6

229

491

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

175.0

98.6

103

H35.6

ICD-10 Finland

Retinal haemorrhage

244.3

93.9

A10AA02, ,

ATC

5.0

92.6

204

422

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

123.5

90.2

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.8

89.2

207

447

H25.0

ICD-10 Finland

Senile incipient cataract

2.6

89.1

552

2238

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

24.5

88.9

S01EC04

ATC

brinzolamide; ophthalmic

3.1

86.8

387

1315

A10AA01, ,

ATC

6.9

86.8

135

200

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.5

85.6

615

2674

WX002

NOMESCO Finland

Sedation and analgesia

2.0

84.2

1224

7031

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

419.1

83.2

CKD15

NOMESCO Finland

Injection of vitreous substitute

+∞

81.5

H3603, E103,

ICD-10 Finland

+∞

80.4

A10AB01

ATC

insulin (human); parenteral

4.8

80.1

185

398

S01EA03

ATC

apraclonidine; ophthalmic

7.8

78.9

110

144

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

779.8

78.6

H44.2

ICD-10 Finland

Degenerative myopia

35.3

77.8

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

76.1

587

2630

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

748.8

75.4

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

13.3

75.0

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.7

70.8

400

1543

H33.5

ICD-10 Finland

Other retinal detachments

16.0

70.1

H40.0

ICD-10 Finland

Glaucoma suspect

2.3

69.5

568

2605

CKC60

NOMESCO Finland

Local buckling of sclera using implant

687.1

69.2

CKC20

NOMESCO Finland

Cryopexy of undetached retina

125.1

69.0

CKC30

NOMESCO Finland

Cryopexy of detached retina

+∞

68.9

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

17.7

68.8

ZXE00

NOMESCO Finland

One hour or less

1.7

66.3

2058

14598

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

65.1

427

1772

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.3

62.0

247

783

H3601, E103,

ICD-10 Finland

+∞

60.5

ZXD20

NOMESCO Finland

Day surgery

2.0

58.0

719

3862

H35.4

ICD-10 Finland

Peripheral retinal degeneration

92.6

58.0

H3600, E103,

ICD-10 Finland

+∞

56.3

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.8

56.3

131

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

17.2

55.7

H52.1

ICD-10 Finland

Myopia

4.0

53.7

157

405

1LA05, ,

NOMESCO Finland

+∞

53.2

CS494

NOMESCO Finland

Other visual field testing

3.4

52.9

195

589

A10AB05

ATC

insulin aspart; parenteral

2.3

52.1

432

1985

A10AB04

ATC

insulin lispro; parenteral

4.2

52.1

141

344

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.9

51.5

152

395

A10AC01

ATC

insulin (human); parenteral

2.3

51.1

414

1884

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

257.8

50.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

48.1

359

1575

T89

ICPC

Diabetes insulin dependent

3.4

48.1

176

529

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

10.7

47.0

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

12.5

46.9

N02BE01

ATC

paracetamol; systemic, rectal

1.9

46.5

4727

42909

Z3231

NOMESCO Finland

Registered nurse

1.6

46.2

1476

10332

A98

ICPC

Health maint/preventive medicine

2.0

45.7

4898

45028

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

45.6

1916

14258

S01EC54

ATC

brinzolamide, combinations; ophthalmic

4.0

44.9

129

329

CKC70

NOMESCO Finland

Circular buckling of sclera

+∞

44.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

44.8

2764

22259

S01EE03

ATC

bimatoprost; ophthalmic

3.0

44.1

198

673

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

82.5

43.9

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

221.8

43.0

H30.2

ICD-10 Finland

Posterior cyclitis

421.0

42.2

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

7.8

42.1

S01EC03

ATC

dorzolamide; ophthalmic

3.6

41.6

138

389

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

7.0

41.5

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

41.1

155

475

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.8

40.9

217

808

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

40.6

619

3537

S01EE05

ATC

tafluprost; ophthalmic

2.5

40.5

273

1143

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.7

39.0

127

A10AE05

ATC

insulin detemir; parenteral

2.4

38.8

277

1191

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.5

37.3

H33.4

ICD-10 Finland

Traction detachment of retina

191.3

36.8

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.9

36.4

111

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.4

34.9

240

1014

H33.2

ICD-10 Finland

Serous retinal detachment

124.2

34.7

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

8.4

34.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

34.3

3311

28383

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.6

34.1

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

2.5

34.1

219

897

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

7.4

33.9

A10AE04

ATC

insulin glargine; parenteral

1.9

33.9

494

2778

S01EE04

ATC

travoprost; ophthalmic

2.9

33.4

162

575

H27.1

ICD-10 Finland

Dislocation of lens

6.4

32.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

32.7

1937

15168

S01FA01

ATC

atropine; ophthalmic

7.4

32.6

H04AA01

ATC

glucagon; nasal, parenteral

5.1

32.4

135

A02BC02

ATC

pantoprazole; systemic

1.4

32.2

3587

31356

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

72.6

31.9

H34.1

ICD-10 Finland

Central retinal artery occlusion

166.0

31.7

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

12.0

30.7

H34.2

ICD-10 Finland

Other retinal artery occlusions

110.7

30.7

H54.7

ICD-10 Finland

Unspecified visual loss

5.7

30.3

J01DB01

ATC

cefalexin; oral

1.5

30.2

4087

36772

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

2.9

30.0

146

520

S01EX03, ,

ATC

2.7

29.5

163

620

A10AD01

ATC

insulin (human); parenteral

3.6

29.4

273

XCH05

NOMESCO Finland

Eye pressure longterm registration

4.1

29.0

194

H02AB06

ATC

prednisolone; systemic

1.4

28.7

2445

20237

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

9.8

28.5

H35.3

ICD-10 Finland

Degeneration of macula and posterior pole

+∞

28.1

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

+∞

28.1

H40.11

ICD-10 Finland

Low pressure glaucoma

2.6

27.5

161

631

CS2P4

NOMESCO Finland

Optic nerve head imaging

4.2

27.4

172

S18

ICPC

Laceration/cut

1.4

27.4

2458

20463

Z2221

NOMESCO Finland

Medical doctor

1.4

27.1

1293

9659

CKD50

NOMESCO Finland

Endodiathermy of retina

+∞

27.1

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

9.5

27.1

H57.1

ICD-10 Finland

Ocular pain

2.5

26.7

175

724

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

26.5

1245

9271

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

26.3

1571

12205

CHD99

NOMESCO Finland

Other filtering operation

8.7

26.3

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

26.1

625

4025

A10AE06

ATC

insulin degludec; parenteral

2.7

26.0

146

560

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.7

26.0

145

555

S01FA04

ATC

cyclopentolate; ophthalmic

3.9

25.7

194

R42

ICD-10 Finland

Dizziness and giddiness

1.4

25.6

1336

10131

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

25.5

210

960

C08CA01

ATC

amlodipine; oral

1.4

25.1

2251

18648

H53.4

ICD-10 Finland

Visual field defects

2.8

24.8

129

476

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.1

24.8

164

F29

ICPC

Eye symptom/complaint other

1.7

24.7

501

3090

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

9.1

23.8

S01BA04

ATC

prednisolone; ophthalmic

2.6

23.7

137

534

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.1

23.3

127

Kela drug reimbursment

Transplant complication

3.8

23.2

181

A02BC05

ATC

esomeprazole; systemic

1.3

23.0

1997

16395

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

22.5

357

2054

AA1AD

NOMESCO Finland

CT of head and brain

1.4

22.4

1676

13432

H35

ICD-10 Finland

Other retinal disorders

32.4

22.4

E10

ICD-10 Finland

Type 1 diabetes mellitus

4.2

22.3

138

C10AA05

ATC

atorvastatin; oral

1.3

22.1

2356

19899

M79.6

ICD-10 Finland

Pain in limb

1.3

21.9

2083

17295

A10AA03, ,

ATC

5.1

21.9

H3602, E113,

ICD-10 Finland

+∞

21.9

SPAT1325

SPAT

Vaccination

1.3

21.8

1816

14779

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

21.7

128

504

SPAT1262

SPAT

Handing over of treatment supplies

1.5

21.7

892

6447

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

21.6

3536

31695

SPAT1312

SPAT

General health counselling

1.4

21.5

1453

11446

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

21.4

643

4356

SPAT1263

SPAT

Sampling

1.3

21.4

2023

16767

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

6.8

21.2

L04AA06

ATC

mycophenolic acid; systemic

3.0

20.9

305

H16.0

ICD-10 Finland

Corneal ulcer

2.1

20.9

210

1039

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

+∞

20.8

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.6

20.8

NHQ40

NOMESCO Finland

Amputation of toe

2.8

20.8

101

360

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

20.6

125

L28

ICPC

Limited function/disability (L)

1.4

20.6

1178

9023

A10AD05

ATC

insulin aspart; parenteral

2.7

20.5

111

419

S01BA01

ATC

dexamethasone; ophthalmic

2.2

20.4

179

840

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.4

20.3

114

L17

ICPC

Foot/toe symptom/complaint

1.4

20.2

1515

12109

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

8.4

20.1

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

20.0

227

1173

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

20.0

1479

11793

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

19.9

1473

11740

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.9

19.9

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

19.8

121

485

E0000UV, ,

ATC

1.3

19.8

1952

16226

H35.29

ICD-10 Finland

Other proliferative retinopathy

200.7

19.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

19.5

2075

17414

H21.0

ICD-10 Finland

Hyphaema

6.0

19.5

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

19.3

1102

8423

J01CA04

ATC

amoxicillin; systemic

1.3

19.2

3827

34940

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.1

19.1

268

Z01.2

ICD-10 Finland

Dental examination

1.3

19.1

1902

15811

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

18.9

3072

27234

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

18.7

1944

16240

XKD00

NOMESCO Finland

Uroflowmetry

1.4

18.7

846

6210

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

18.6

1062

8112

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

18.6

1801

14898

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

18.4

2758

24154

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

18.3

752

5421

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

6.9

18.2

H43.3

ICD-10 Finland

Other vitreous opacities

3.1

18.2

239

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

18.1

1378

11000

R53

ICD-10 Finland

Malaise and fatigue

1.4

18.1

1259

9917

UJF32

NOMESCO Finland

Coloscopy

1.3

17.9

1368

10926

R06.0

ICD-10 Finland

Dyspnoea

1.3

17.8

1448

11666

C03CA01

ATC

furosemide; systemic

1.3

17.8

1988

16736

H44.0

ICD-10 Finland

Purulent endophthalmitis

26.8

17.8

SPAT1153

SPAT

Removal of sutures

1.3

17.8

1599

13072

Z71.8

ICD-10 Finland

Other specified counselling

1.3

17.7

1467

11850

R51.80

ICD-10 Finland

Headache

1.5

17.7

622

4345

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

+∞

17.7

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

36.8

17.6

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

3.3

17.2

191

S29

ICPC

Skin symptom/complaint other

1.4

17.1

1014

7781

R01AD09

ATC

mometasone; nasal

1.3

17.0

1829

15292

S01BA07

ATC

fluorometholone; ophthalmic

2.8

17.0

308

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

17.0

2240

19230

G04CA02

ATC

tamsulosin; oral

1.3

16.9

1250

9919

L03

ICPC

Low back symptom/complaint

1.3

16.9

1306

10433

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

16.9

1377

11089

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

16.8

263

1508

1LA01, ,

NOMESCO Finland

+∞

16.7

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

16.6

112

471

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

16.6

1347

10833

B05DA

ATC

Isotonic solutions

4.5

16.6

A11CC03

ATC

alfacalcidol; systemic

2.3

16.4

119

517

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

16.4

1244

9905

SPAT1310

SPAT

Counselling related to known health issue

1.3

16.4

1476

12040

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

16.3

350

2187

S01ED02

ATC

betaxolol; ophthalmic

2.9

16.2

250

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.5

16.2

C07AB07

ATC

bisoprolol; oral

1.3

16.1

2755

24353

CKA10

NOMESCO Finland

Biopsy of vitreous body

30.1

16.1

H27.0

ICD-10 Finland

Aphakia

6.0

16.0

C10AA01

ATC

simvastatin; oral

1.3

16.0

2457

21436

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

13.6

15.9

J01AA02

ATC

doxycycline; systemic

1.3

15.9

3818

35166

H26.3

ICD-10 Finland

Drug-induced cataract

4.4

15.9

A12AA04

ATC

calcium carbonate; oral

2.8

15.8

276

137

Kela drug reimbursment

Uraemia requiring dialysis

4.0

15.7

111

H30.1

ICD-10 Finland

Disseminated chorioretinal inflammation

+∞

15.6

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.7

15.6

306

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

15.5

525

3639

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

15.4

2012

17185

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

4.4

15.4

L01

ICPC

Neck symptom/complaint

1.4

15.3

689

5038

K02.1

ICD-10 Finland

Caries of dentine

1.3

15.3

2360

20559

J02AC01

ATC

fluconazole; systemic

1.3

15.3

1570

13010

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

15.2

1709

14326

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.2

15.1

181

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

15.1

160

808

N03AX12

ATC

[U] gabapentin; oral

1.4

15.1

756

5634

J01FA10

ATC

azithromycin; systemic

1.3

15.0

2290

19906

F05

ICPC

Visual disturbance other

2.0

15.0

154

769

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

15.0

2287

19885

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

6.5

14.9

CKD60

NOMESCO Finland

Anterior vitrectomy

3.2

14.9

188

H53.8

ICD-10 Finland

Other visual disturbances

2.8

14.8

252

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

14.8

745

5555

J01MA02

ATC

ciprofloxacin; systemic

1.3

14.7

1953

16685

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.9

14.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

14.7

1266

10238

B05DB

ATC

Hypertonic solutions

4.4

14.7

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

14.6

347

2224

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

+∞

14.6

H30.8

ICD-10 Finland

Other chorioretinal inflammations

+∞

14.6

M01AB05

ATC

diclofenac; systemic, rectal

1.3

14.5

2990

26867

H31.0

ICD-10 Finland

Chorioretinal scars

150.4

14.5

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.2

14.5

114

514

H81

ICPC

Excessive ear wax

1.3

14.4

956

7445

N03AX16

ATC

[U] pregabalin

1.3

14.4

1085

8609

SFA10

NOMESCO Finland

One-surface restoration

1.3

14.4

2268

19759

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.1

14.3

128

607

ZXD05

NOMESCO Finland

Urgent procedure

1.3

14.2

1368

11221

CK2X4, ,

SPAT

10.4

14.2

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.3

14.2

SDA03

NOMESCO Finland

Periodontal treatment

1.3

14.2

1564

13053

D07AC01

ATC

betamethasone; topical

1.3

14.1

1686

14208

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.1

14.1

131

631

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

14.1

1343

11001

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

14.0

689

5112

J01FF01

ATC

clindamycin; systemic

1.3

14.0

1192

9614

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

14.0

494

3450

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

3.4

13.8

141

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

13.7

1711

14484

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.5

13.6

340

H20.8

ICD-10 Finland

Other iridocyclitis

4.9

13.6

S97

ICPC

Chronic ulcer skin

1.6

13.6

345

2247

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

34.1

13.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

13.5

1577

13241

T90

ICPC

Diabetes non-insulin dependent

1.3

13.4

1216

9883

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.3

1759

14974

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

13.3

1132

9120

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

10.5

13.2

CK2Z4

NOMESCO Finland

Ocular fundus light imaging (OCT), angiography

40.2

13.1

R05

ICD-10 Finland

Cough

1.3

13.1

977

7728

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

13.1

265

1632

H40

ICD-10 Finland

Glaucoma

2.6

13.1

287

M03BX02

ATC

tizanidine; oral

1.2

13.0

2583

22990

H53.2

ICD-10 Finland

Diplopia

1.9

13.0

161

860

S01FA02

ATC

scopolamine; ophthalmic

3.2

13.0

157

CA1AD

NOMESCO Finland

Orbita CT

9.3

12.9

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

13.0

12.9

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

12.9

1033

8253

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

22.6

12.9

N02AX02

ATC

tramadol; systemic, rectal

1.2

12.9

2078

18079

Z01.7

ICD-10 Finland

Laboratory examination

1.4

12.8

726

5511

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

12.8

1028

8214

F38

ICPC

Eye, Other laboratory test NEC

2.3

12.8

387

SFA20

NOMESCO Finland

Two-surface restoration

1.2

12.7

2319

20436

R01AD12

ATC

fluticasone furoate; nasal

1.3

12.7

1081

8708

J01MA12

ATC

levofloxacin; systemic

1.3

12.7

913

7186

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

12.6

1142

9275

N06AX11

ATC

mirtazapine; oral

1.3

12.5

1578

13339

CKD45

NOMESCO Finland

Endocryotherapy of retina

+∞

12.5

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.1

12.5

166

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

10.0

12.5

SPAT1260

SPAT

Consultation of another employee

1.3

12.4

818

6350

H54.5

ICD-10 Finland

Severe visual impairment, monocular

4.2

12.4

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

12.4

487

3470

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

12.4

301

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

12.4

1050

8449

G44.2

ICD-10 Finland

Tension-type headache

1.4

12.3

524

3788

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

12.0

561

4121

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

12.0

265

1669

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

12.0

1391

11636

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

5.0

11.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

11.9

1012

8140

C10AA07

ATC

rosuvastatin; oral

1.3

11.9

1575

13373

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

11.9

1451

12208

D01

ICPC

Abdominal pain/cramps general

1.4

11.8

492

3542

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

11.8

1127

9203

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.8

1847

15975

H18.2

ICD-10 Finland

Other corneal oedema

5.9

11.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

11.8

1832

15833

S01AX11

ATC

[U] ofloxacin

1.8

11.7

169

947

G47.3

ICD-10 Finland

Sleep apnoea

1.3

11.7

896

7102

B01AC04

ATC

clopidogrel; oral

1.3

11.6

922

7346

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

11.6

728

5609

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

11.5

259

1639

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.5

11.5

113

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

11.5

388

2687

UKC02

NOMESCO Finland

Cystoscopy

1.3

11.5

855

6754

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

120.3

11.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

11.4

337

2269

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

11.4

905

7209

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

11.4

231

H92.0

ICD-10 Finland

Otalgia

1.6

11.4

233

1441

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.4

1077

8781

L04AX03

ATC

methotrexate; systemic

1.5

11.3

397

2767

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

11.3

468

3368

K30

ICD-10 Finland

Functional dyspepsia

1.4

11.2

486

3524

CHD00

NOMESCO Finland

Laser trabeculoplasty

2.3

11.2

335

M54.5

ICD-10 Finland

Low back pain

1.2

11.1

1548

13197

L04AX01

ATC

azathioprine; systemic

1.8

11.1

164

927

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

11.0

1003

8130

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

11.0

261

1673

H01.0

ICD-10 Finland

Blepharitis

1.6

11.0

243

1532

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

11.0

557

4150

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.1

11.0

105

513

F01

ICPC

Eye pain

2.0

10.9

115

583

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

10.8

595

4490

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.8

10.8

186

H46

ICD-10 Finland

Optic neuritis

3.9

10.8

A01

ICPC

Pain general/multiple sites

1.4

10.8

490

3583

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.0

10.8

109

544

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

10.8

490

3585

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

10.7

1396

11803

J05AB01

ATC

aciclovir; systemic

1.3

10.7

956

7729

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

10.7

313

2104

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

10.6

924

7443

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

10.6

845

6729

M48.0

ICD-10 Finland

Spinal stenosis

1.3

10.6

675

5209

SPAT1301

SPAT

No procedures

1.2

10.5

1541

13193

L04AD01

ATC

ciclosporin; systemic

2.4

10.5

276

H33

ICD-10 Finland

Retinal detachments and breaks

14.2

10.5

C08CA13

ATC

lercanidipine; oral

1.3

10.5

775

6111

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

110.2

10.4

H3601, E107,

ICD-10 Finland

+∞

10.4

H3602, E103,

ICD-10 Finland

+∞

10.4

L12

ICPC

Hand/finger symptom/complaint

1.3

10.4

711

5543

M25.5

ICD-10 Finland

Pain in joint

1.2

10.4

1333

11248

R21

ICPC

Throat symptom/complaint

1.3

10.4

644

4950

Z5132

NOMESCO Finland

Nursing associate professional

3.9

10.4

G04CB02

ATC

dutasteride; oral

1.4

10.3

389

2751

C08CA02

ATC

felodipine; oral

1.4

10.3

527

3931

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

10.2

261

1703

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

10.2

117

611

R01AD08

ATC

fluticasone; nasal

1.3

10.2

1071

8833

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

10.1

1535

13179

L04AD02

ATC

tacrolimus; systemic

3.4

10.1

103

TK800

NOMESCO Finland

Hemodialysis

2.1

10.1

415

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

10.1

915

7407

SPAT1097

SPAT

Recording of ECG

1.3

10.1

728

5718

R03AC02

ATC

salbutamol; inhalant

1.2

10.1

2397

21519

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.8

10.0

166

CFW99

NOMESCO Finland

Other operation on conjunctiva

5.0

10.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

10.0

866

6971

C02AC05

ATC

moxonidine; oral

1.6

10.0

230

1466

U02

ICPC

Urinary frequency/urgency

1.3

10.0

705

5522

K85

ICPC

Elevated blood pressure

1.3

9.9

904

7322

Z49.2

ICD-10 Finland

Other dialysis

3.5

9.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.8

9.8

174

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

9.8

815

6527

C09CA06

ATC

candesartan; oral

1.3

9.7

1069

8854

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

9.7

917

7458

KMAK, ,

NOMESCO Finland

1.2

9.7

1975

17448

C01DA14

ATC

isosorbide mononitrate; oral

1.3

9.7

967

7921

R06AE09

ATC

levocetirizine; oral

1.4

9.6

484

3598

1LA04, ,

NOMESCO Finland

55.1

9.6

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

9.6

327

2268

H47.1

ICD-10 Finland

Papilloedema, unspecified

3.9

9.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

9.6

587

4504

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

9.5

953

7803

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

9.5

1110

9253

M79.1

ICD-10 Finland

Myalgia

1.3

9.5

569

4348

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

9.5

215

1365

H13

ICPC

Plugged feeling ear

1.3

9.5

995

8197

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

9.5

1241

10482

CHD35

NOMESCO Finland

Laser goniopuncture

3.3

9.4

108

F99

ICPC

Eye/adnexa disease other

2.8

9.4

161

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

9.4

832

6710

H3603, E107,

ICD-10 Finland

+∞

9.4

H3601, E116,

ICD-10 Finland

+∞

9.4

CKC75

NOMESCO Finland

Removal of cerclage from sclera

+∞

9.4

H35.1

ICD-10 Finland

Retinopathy of prematurity

+∞

9.4

CKD85

NOMESCO Finland

Removal of subretinal membrane or band

+∞

9.4

C09CA01

ATC

losartan; oral

1.2

9.4

1318

11214

N17

ICPC

Vertigo/dizziness

1.3

9.4

671

5263

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

21.7

9.3

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

2.4

9.3

243

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

9.3

1398

11977

R02

ICPC

Shortness of breath/dyspnoea

1.3

9.3

671

5271

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

9.2

828

6687

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.0

9.2

136

TK820

NOMESCO Finland

Peritoneal dialysis

4.2

9.2

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

9.2

1195

10083

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

9.1

748

5975

P01BA02

ATC

hydroxychloroquine; oral

1.4

9.1

351

2495

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

9.1

603

4680

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

9.1

497

3748

S01AD03

ATC

aciclovir; ophthalmic

1.7

9.1

151

886

F43

ICPC

Eye, Other diagnostic procedure

2.0

9.0

461

H02

ICPC

Hearing complaint

1.3

9.0

793

6388

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

9.0

1781

15662

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

9.0

106

G04BD12

ATC

mirabegron; oral

1.3

9.0

660

5192

B01AB05

ATC

enoxaparin; parenteral

1.2

9.0

1570

13645

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

8.9

1594

13882

D06

ICPC

Abdominal pain localized other

1.4

8.9

356

2548

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

8.9

262

1767

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

4.9

8.8

M65.3

ICD-10 Finland

Trigger finger

1.6

8.8

189

1185

L04AA01

ATC

[U] ciclosporin

2.4

8.8

256

L13

ICPC

Hip symptom/complaint

1.3

8.8

970

8028

A97

ICPC

No disease

1.3

8.8

904

7422

SPAT1211

SPAT

Application of soft bandage

1.4

8.8

394

2875

H53.0

ICD-10 Finland

Amblyopia ex anopsia

3.1

8.8

113

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

8.8

615

4808

A05

ICPC

Feeling ill

1.6

8.8

200

1273

M10

ICD-10 Finland

Gout

1.6

8.8

215

1392

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

9.5

8.8

UDC00

NOMESCO Finland

Ear microscopy

1.5

8.7

314

2201

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

8.7

489

3701

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.7

396

2899

M01AH05

ATC

etoricoxib; oral

1.2

8.7

2613

23841

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

8.7

459

3443

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.9

8.6

106

567

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

8.6

260

1760

D07AC13

ATC

mometasone; topical

1.2

8.6

1221

10381

SPAT1254

SPAT

Administration of medicine

1.3

8.6

754

6068

Z2446

NOMESCO Finland

Social worker

1.5

8.6

242

1614

M45

ICD-10 Finland

Ankylosing spondylitis

2.2

8.6

335

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

8.6

434

3230

G04CB01

ATC

finasteride; oral

1.3

8.6

571

4430

H18.1

ICD-10 Finland

Bullous keratopathy

4.6

8.6

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

8.6

266

1812

N05BA04

ATC

oxazepam; oral

1.2

8.6

1192

10117

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.5

2843

26146

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

8.5

448

3357

C09AA02

ATC

enalapril; systemic

1.2

8.5

1016

8485

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.5

1706

15009

J01DA01

ATC

[U] cefalexin

1.2

8.5

2791

25639

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

8.5

1260

10767

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

8.5

164

1003

A10BB01

ATC

glibenclamide; oral

1.6

8.4

205

1324

M02AA07

ATC

piroxicam; topical

1.2

8.4

1757

15503

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.0

8.4

116

TAB00

NOMESCO Finland

Lumbar puncture

1.7

8.4

154

928

L16

ICPC

Ankle symptom/complaint

1.3

8.4

478

3625

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.7

8.4

139

815

A08

ICPC

Swelling

1.5

8.4

302

2119

C09AA05

ATC

ramipril; oral

1.2

8.4

1343

11559

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

8.4

853

6993

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

8.4

209

1359

SPAT1053

SPAT

Memory test

1.3

8.4

883

7269

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

8.3

4115

39157

H31.4

ICD-10 Finland

Choroidal detachment

+∞

8.3

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

+∞

8.3

37600

ICD-8 Finland

Detachment of retina, Primaria

+∞

8.3

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

8.3

161

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.3

8.3

276

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

8.3

329

2351

L57.0

ICD-10 Finland

Actinic keratosis

1.3

8.3

625

4936

P20

ICPC

Memory disturbance

1.3

8.3

909

7518

-44

ICPC

Preventive immunization/medic

1.4

8.3

396

2923

H91.1

ICD-10 Finland

Presbycusis

1.4

8.2

413

3070

R4110, ,

SPAT

1.3

8.2

616

4858

V03AE01

ATC

polystyrene sulfonate; oral

2.3

8.2

277

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

8.2

295

2069

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

3.2

8.2

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

8.2

435

3264

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

8.2

290

2029

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.4

8.1

N06AB06

ATC

sertraline; oral

1.4

8.1

377

2768

NGQ20

NOMESCO Finland

Amputation of lower leg

3.1

8.1

108

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.1

807

6596

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.4

8.1

V03AE02

ATC

sevelamer; oral

3.8

8.1

B01AF02

ATC

apixaban; oral

1.3

8.0

772

6284

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

22.0

8.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.0

425

3189

C10AX09

ATC

ezetimibe; oral

1.3

8.0

767

6243

N30.0

ICD-10 Finland

Acute cystitis

1.3

8.0

817

6701

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

8.0

601

4745

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.9

802

6566

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

7.9

421

3159

J01FA09

ATC

clarithromycin; systemic

1.2

7.9

1192

10187

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

7.9

1015

8533

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.3

7.9

J01CF05

ATC

flucloxacillin; systemic

1.5

7.9

273

1901

R07.0

ICD-10 Finland

Pain in throat

1.5

7.9

224

1499

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

7.9

782

6388

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

7.8

239

1624

R06AE07

ATC

cetirizine; oral

1.2

7.8

1783

15835

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.8

7.8

102

558

M01AE02

ATC

naproxen; oral, rectal

1.2

7.8

2339

21263

H02.3

ICD-10 Finland

Blepharochalasis

1.4

7.8

306

2184

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

7.8

998

8391

N03AE01

ATC

clonazepam; systemic

1.5

7.7

242

1652

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

7.7

326

2355

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

4.2

7.7

3643

FHL

Vitrectomy through pars Plana

15.0

7.7

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

7.7

1056

8938

D82

ICPC

Teeth/gum disease

1.2

7.7

1315

11375

A10AD04

ATC

insulin lispro; parenteral

4.3

7.7

R60.0

ICD-10 Finland

Localized oedema

1.3

7.7

660

5299

N06AX21

ATC

duloxetine; oral

1.3

7.7

449

3421

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.6

1646

14542

XF402

NOMESCO Finland

ECG with work load test

1.3

7.6

500

3872

R06AX27

ATC

desloratadine; oral

1.2

7.6

949

7952

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

18.4

7.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

7.6

352

2585

R35

ICD-10 Finland

Polyuria

1.4

7.6

327

2372

H44.1

ICD-10 Finland

Other endophthalmitis

11.8

7.6

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.6

1695

15023

SPAT1229

SPAT

Assessment of need for aid

1.4

7.5

406

3053

C03DA01

ATC

spironolactone; oral

1.3

7.5

647

5192

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.5

732

5964

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

7.5

739

6029

I95.1

ICD-10 Finland

Orthostatic hypotension

1.5

7.5

229

1556

S22

ICPC

Nail symptom/complaint

1.4

7.5

291

2071

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.5

402

3022

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.5

7.5

170

OAB50, ,

SPAT

1.4

7.5

336

2455

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

7.5

179

1155

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

7.4

267

1873

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

7.4

1023

8657

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

7.4

254

1765

M01AH01

ATC

celecoxib; oral

1.2

7.4

820

6778

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

7.4

318

2304

C07AB02

ATC

metoprolol; systemic

1.2

7.4

1088

9270

R05

ICPC

Cough

1.2

7.4

1044

8861

A10BB07

ATC

glipizide; oral

2.1

7.4

337

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

7.3

190

1247

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

7.3

527

4132

R04.0

ICD-10 Finland

Epistaxis

1.4

7.3

384

2876

A07AA02

ATC

nystatin; oral

1.4

7.3

280

1988

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.8

7.3

519

N48.4

ICD-10 Finland

Impotence of organic origin

1.9

7.3

498

H3601, E117,

ICD-10 Finland

+∞

7.3

207

Kela drug reimbursment

Chronic arrhythmias

1.2

7.3

935

7855

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.3

1099

9386

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

7.3

351

2594

M54.3

ICD-10 Finland

Sciatica

1.5

7.3

239

1649

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

4.1

7.3

S01EB01

ATC

pilocarpine; ophthalmic

2.5

7.2

173

R52.9

ICD-10 Finland

Pain, unspecified

1.3

7.2

433

3310

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

7.2

366

2727

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

7.2

317

2307

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

7.2

108

618

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

7.1

1015

8615

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

7.1

1112

9525

M01AH02

ATC

rofecoxib; oral

1.3

7.1

605

4848

H84

ICPC

Presbyacusis

1.5

7.1

235

1623

G04CA01

ATC

alfuzosin; oral

1.3

7.1

552

4372

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

7.1

691

5628

S04

ICPC

Lump/swelling localized

1.3

7.1

436

3344

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

7.1

684

5565

H50.2

ICD-10 Finland

Vertical strabismus

2.7

7.1

128

H28.0*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic cataract

7.9

7.1

AN1

Coronary angiography

1.3

7.1

585

4672

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.3

7.0

231

SFA30

NOMESCO Finland

Three-surface restoration

1.2

7.0

1673

14883

J01MA06

ATC

norfloxacin; oral

1.3

7.0

581

4641

D07AD01

ATC

clobetasol; topical

1.3

7.0

698

5704

R51

ICD-10 Finland

Headache

1.6

7.0

170

1102

A02BC03

ATC

lansoprazole; oral

1.2

7.0

1333

11636

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

2.4

6.9

201

R50.9

ICD-10 Finland

Fever, unspecified

1.3

6.9

635

5136

A02BC01

ATC

omeprazole; systemic

1.2

6.9

1289

11225

205

Kela drug reimbursment

Chronic hypertension

1.2

6.9

1496

13199

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.6

6.9

134

822

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

6.9

189

1257

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.5

6.9

186

1233

W19

ICD-10 Finland

Unspecified fall

1.3

6.9

450

3483

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.7

6.9

136

A10AB06

ATC

insulin glulisine; parenteral

2.6

6.9

142

H40.8

ICD-10 Finland

Other glaucoma

3.1

6.8

H53

ICD-10 Finland

Visual disturbances

2.8

6.8

114

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.8

6.8

114

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

2.5

6.8

172

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

6.8

289

2091

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

6.8

326

2407

H54.1

ICD-10 Finland

Severe visual impairment, binocular

8.3

6.8

R55

ICD-10 Finland

Syncope and collapse

1.3

6.8

559

4461

C03AA03

ATC

hydrochlorothiazide; oral

1.3

6.8

476

3722

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

2.6

6.8

143

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

6.8

120

719

J01FA06

ATC

roxithromycin; oral

1.2

6.8

1726

15432

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

40.1

6.8

3745

FHL

Hard membrane girding, cerclage with coagulation

40.1

6.8

WX402

NOMESCO Finland

General anaesthesia

1.2

6.7

849

7116

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.7

377

2854

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

6.7

420

3231

CHC05

NOMESCO Finland

Iridotomy

1.9

6.7

405

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.7

1442

12710

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.8

6.7

491

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

6.7

786

6540

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

6.7

321

2374

N06AX16

ATC

venlafaxine; oral

1.3

6.6

458

3572

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

6.6

585

4709

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

6.6

355

2669

A29

ICPC

General symptom/complaint other

1.3

6.6

656

5354

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

6.6

814

6804

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.4

6.6

245

1731

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

6.6

438

3397

A10BA02

ATC

metformin; oral

1.2

6.6

1369

12024

SPAT1377

SPAT

Polysomnography

1.7

6.6

111

656

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

6.6

335

2498

BEF00, ,

SPAT

2.7

6.6

122

U07

ICPC

Urine symptom/complaint other

1.3

6.6

400

3066

P06

ICPC

Sleep disturbance

1.3

6.6

438

3401

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

6.5

546

4365

ZY010

NOMESCO Finland

Hospital outpatient

1.6

6.5

142

896

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.5

582

4690

S01.50

ICD-10 Finland

Open wound in oral cavity

2.3

6.5

213

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.5

1068

9182

XX2RW, ,

NOMESCO Finland

2.1

6.5

299

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

6.5

226

1579

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

6.5

134

836

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

2.8

6.5

112

ZXD35

NOMESCO Finland

Usual procedure

1.6

6.5

133

829

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

6.5

224

1564

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

6.4

335

2508

H34.0

ICD-10 Finland

Transient retinal artery occlusion

69.9

6.4

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

69.9

6.4

B03XA02

ATC

darbepoetin alfa; parenteral

1.8

6.4

527

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

6.4

656

5374

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.7

6.4

113

677

SPAT1009

SPAT

Measurement of intraocular pressure

2.0

6.4

342

L02

ICPC

Back symptom/complaint

1.3

6.3

366

2786

E03

ICD-10 Finland

Other hypothyroidism

1.4

6.3

246

1756

SPAT1281

SPAT

Other administrative function

1.4

6.3

313

2327

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

6.3

817

6867

M10.9

ICD-10 Finland

Gout, unspecified

1.4

6.3

336

2527

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.3

1742

15660

RJ420, ,

NOMESCO Finland

3.3

6.3

H3603, E116,

ICD-10 Finland

+∞

6.2

Q82.84

ICD-10 Finland

Pseudoxanthoma elasticum

+∞

6.2

H3601, E106,

ICD-10 Finland

+∞

6.2

H3601, E119,

ICD-10 Finland

+∞

6.2

H360, E103,

ICD-10 Finland

+∞

6.2

H35.20

ICD-10 Finland

Proliferative vitreoretinopathy

+∞

6.2

A02BA02

ATC

ranitidine; systemic

1.2

6.2

932

7941

N02BF01

ATC

gabapentin; oral

1.3

6.2

416

3231

SPAT1216

SPAT

Assessment of functional ability

1.2

6.2

845

7134

M01AC06

ATC

meloxicam; systemic, rectal

1.2

6.2

1592

14218

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

6.2

222

1559

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

7.0

6.2

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

6.2

168

1116

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

6.2

111

668

H02.1

ICD-10 Finland

Ectropion of eyelid

2.0

6.2

339

J45

ICD-10 Finland

Asthma

1.3

6.2

390

3006

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.2

751

6270

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

6.2

222

1562

D01BA02

ATC

terbinafine; oral

1.2

6.1

1090

9439

H16.9

ICD-10 Finland

Keratitis, unspecified

2.0

6.1

299

C09CA07

ATC

telmisartan; oral

1.4

6.1

324

2433

WX290

NOMESCO Finland

Other blockage of nerve

1.2

6.1

1566

13982

R31

ICD-10 Finland

Unspecified haematuria

1.3

6.1

501

3998

SFA00

NOMESCO Finland

Small restoration

1.3

6.1

511

4088

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

2.5

6.1

145

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

12.5

6.1

171

Kela drug reimbursment

Degludekinsuliini

12.5

6.1

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

6.1

149

969

H02AB04

ATC

methylprednisolone; systemic

1.3

6.1

600

4897

R4180

NOMESCO Finland

Podiatric therapy

2.2

6.0

227

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

8.6

6.0

A04

ICPC

Weakness/tiredness general

1.2

6.0

743

6210

RK220, ,

NOMESCO Finland

3.6

6.0

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

6.7

6.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

6.0

214

1502

S22.3

ICD-10 Finland

Fracture of rib

1.4

6.0

304

2267

D06BX01

ATC

metronidazole; topical

1.3

6.0

400

3106

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

4933

44833

2.27

58.04

28.1

23.7

4.00

3.99

mmol/l

0.28

4843

43844

(3019550) Sodium [Moles/volume] in Serum or Plasma

4929

44782

2.27

58.04

27.8

23.5

139.51

139.58

mmol/l

0.98

4845

43856

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4625

41138

1.91

56.76

22.6

19.3

71.20

73.46

ml/min/173m2

11.72

4369

38446

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3980

34020

1.66

54.99

5.5

4.6

15.23

14.38

mm/h

2.33

3676

31450

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4608

41098

1.87

53.80

8.3

7.0

40.99

39.88

mmol/mol

12.61

4208

37706

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4974

45582

2.28

53.54

30.7

25.8

86.79

81.10

umol/l

13.13

4922

44889

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4776

43167

1.98

52.51

23.1

19.3

26.20

27.08

mg/l

1.00

4135

36615

(3010813) Leukocytes [#/volume] in Blood

4987

45952

2.24

49.53

35.2

29.1

6.90

e9/l

0.03

4859

44623

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4713

42577

1.89

49.43

6.9

6.2

2.48

2.58

mmol/l

12.43

4250

38809

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4516

40277

1.77

49.41

6.4

5.6

2.02

2.03

mu/l

0.22

4073

36602

(3007461) Platelets [#/volume] in Blood

4985

45942

2.23

49.22

35.2

29.1

242.37

244.57

e9/l

1.53

4872

44810

(3000963) Hemoglobin [Mass/volume] in Blood

4986

45956

2.23

49.20

35.5

29.3

130.91

132.01

g/l

5.65

4926

45316

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4985

45946

2.23

49.14

35.1

29.0

91.87

91.73

1.38

4927

45277

(3035941) MCH [Entitic mass]

4985

45947

2.23

49.12

35.0

28.9

30.40

0.03

4926

45278

(3026361) Erythrocytes [#/volume] in Blood

4985

45949

2.23

49.08

35.1

29.0

4.34

4.38

e12/l

4.76

4857

44627

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4984

45950

2.22

48.81

35.7

29.6

39.18

39.48

3.20

4923

45264

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4899

44905

2.07

48.23

15.4

13.0

24.64

24.66

u/l

0.02

4716

43293

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4170

36493

1.64

47.92

9.3

8.4

83.97

81.95

u/l

0.99

3922

34492

(3006315) Basophils [#/volume] in Blood

2921

23686

1.51

46.59

6.9

6.0

0.04

e9/l

0.29

2514

19932

(3001604) Monocytes [#/volume] in Blood

2903

23578

1.50

45.45

6.9

6.0

0.62

0.61

e9/l

1.09

2494

19831

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4584

41291

1.77

45.43

6.0

5.2

1.47

mmol/l

0.04

4109

37468

(3019198) Lymphocytes [#/volume] in Blood

2952

24071

1.50

45.25

7.0

6.1

1.78

1.86

e9/l

1.37

2579

20746

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4609

41628

1.77

44.62

6.0

5.4

4.40

4.51

mmol/l

9.89

4163

38072

(3031040) Bacteria [#/volume] in Urine by Automated count

3741

32118

1.55

44.51

6.2

5.5

2007.52

2068.04

e6/l

0.02

520

(3013115) Eosinophils [#/volume] in Blood

2976

24354

1.50

44.48

7.1

6.2

0.19

e9/l

0.10

2575

20837

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3907

33901

1.56

44.00

5.0

4.5

15.10

15.07

pmol/l

0.26

3478

30610

(3013650) Neutrophils [#/volume] in Blood by Automated count

3215

26811

1.50

43.20

9.5

9.4

4.40

4.28

e9/l

1.87

2791

22975

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2322

18149

1.49

42.96

3.7

3.4

1798.05

1689.73

ng/l

0.48

2018

15939

(3021601) Nitrite [Presence] in Urine by Test strip

3025

24949

1.49

42.70

5.0

4.4

0.00

estimate

0.52

684

5291

(3035350) Ketones [Presence] in Urine by Test strip

3046

25266

1.48

40.99

5.1

4.4

4.19

3.69

estimate

0.06

709

5499

(3032080) INR in Blood by Coagulation assay

3037

25191

1.47

40.77

21.2

18.6

1.35

1.34

inr

0.21

2588

21154

(3009261) Glucose [Presence] in Urine by Test strip

3060

25441

1.47

40.43

5.1

4.4

0.01

0.27

estimate

0.70

670

5173

(3002030) Lymphocytes/Leukocytes in Blood

2728

22210

1.47

39.96

7.2

6.3

25.52

26.24

2.80

2561

20890

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4403

39567

1.63

39.93

5.0

4.5

1.27

mmol/l

0.31

3895

35418

(3018095) Leukocytes [#/volume] in Urine

2380

18880

1.47

39.83

4.9

4.2

139.15

121.59

e6/l

0.31

1735

13569

(3019069) Monocytes/Leukocytes in Blood

2697

21921

1.46

39.77

7.2

6.4

9.09

9.10

0.01

2505

20355

(3006504) Eosinophils/Leukocytes in Blood

2690

21875

1.46

39.43

7.1

6.3

2.81

0.05

2501

20319

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2101

16304

1.48

39.14

2.4

2.2

179.98

226.91

u/l

1.67

1961

15309

(3022096) Basophils/Leukocytes in Blood

2688

21875

1.46

39.12

7.2

6.4

0.66

0.13

2499

20311

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3200

26953

1.47

38.72

8.2

7.1

1.21

mmol/l

0.23

2678

23121

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2678

21831

1.45

38.30

2.7

2.4

80.78

79.75

nmol/l

1.07

2349

19318

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2851

23520

1.45

38.26

2.5

2.3

96.35

94.51

pmol/l

1.18

1482

12212

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4606

42006

1.69

37.80

6.4

5.7

6.13

6.02

mmol/l

6.17

4088

37810

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2533

20491

1.45

37.38

3.7

3.1

141.46

147.00

ug/l

0.52

2285

18761

(3018010) Neutrophils/Leukocytes in Blood

2657

21729

1.44

36.74

7.1

6.2

59.07

58.46

1.88

2525

20608

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2490

20156

1.44

36.18

5.0

4.3

92.99

77.61

ng/l

0.15

2012

15653

(42870588) Differential panel, method unspecified - Blood

2090

16403

1.45

35.73

6.7

6.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2896

24184

1.43

34.97

7.5

6.5

1.21

mmol/l

0.04

2634

22196

(3002582) Erythrocytes [#/volume] in Urine

2153

17055

1.44

34.71

4.1

3.6

125.30

72.07

e6/l

0.44

1686

13150

(3013826) Glucose [Moles/volume] in Serum or Plasma

3408

29351

1.44

34.51

5.8

5.1

6.96

6.76

mmol/l

5.86

3258

27935

(3021589) Normoblasts [#/volume] in Blood

2469

20188

1.41

32.67

14.6

12.4

0.00

e9/l

0.30

2055

16334

(3015736) pH of Urine

2461

20185

1.41

31.60

4.5

3.9

6.35

6.28

2.23

1339

10884

(3024561) Albumin [Mass/volume] in Serum or Plasma

2817

23676

1.40

31.18

5.4

4.9

34.63

34.75

g/l

0.48

2612

22017

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3083

26332

1.40

30.93

6.3

6.5

12.53

12.19

umol/l

0.44

2905

25110

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

347

1789

2.00

30.78

1.8

39.71

38.21

u/l

0.69

305

1530

(40768804) Tissue Pathology biopsy report

2273

18487

1.40

30.17

2.4

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3132

26944

1.39

29.34

3.7

3.3

57.71

54.01

u/l

1.00

2878

24753

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

800

5361

1.58

28.45

3.9

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2010

16154

1.39

27.99

1.9

1.8

21.18

20.21

nmol/l

1.84

1657

13573

(3000850) Epithelial cells [#/volume] in Urine

1555

11972

1.42

27.74

3.1

2.8

4.83

5.50

e6/l

1.30

1414

10907

(3013512) EKG study

2194

17962

1.38

26.98

4.7

4.1

0.86

0.72

—

(3037522) Nuclear Ab [Titer] in Serum

831

5691

1.54

26.71

1.4

1.3

654.75

482.05

titre

1.43

198

1308

(3030467) Casts [#/volume] in Urine by Automated count

1848

14760

1.38

26.26

3.9

3.5

0.42

0.49

e6/l

0.84

1407

11007

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1180

8710

1.46

26.24

3.2

2.6

2.23

2.27

g/l

1.49

1054

7980

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1793

14264

1.39

26.04

2.7

2.4

2.95

mg/l

0.02

1519

12225

(3044889) 12 lead EKG panel

3607

32076

1.38

25.68

5.2

4.6

0.67

5351.48

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2216

18276

1.36

25.57

3.2

3.5

2.35

2.36

mmol/l

2.33

1989

16369

(3023368) Bacteria identified in Blood by Culture

1938

15710

1.37

24.71

4.9

4.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1786

14303

1.37

24.54

5.1

4.6

0.00

estimate

1.34

600

4807

(3022948) Iron [Moles/volume] in Serum or Plasma

1237

9327

1.42

24.23

3.2

2.6

11.82

12.02

umol/l

0.45

1116

8608

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2229

18526

1.35

23.93

5.1

4.5

0.38

0.56

estimate

0.22

579

4304

(3018418) pH of Serum or Plasma

2002

16406

1.35

23.45

5.1

4.1

7.40

0.40

1469

11908

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1092

8111

1.44

23.08

3.2

2.6

21.64

21.38

0.24

980

7487

(3020682) Albumin/Creatinine [Ratio] in Urine

2074

17118

1.35

23.05

4.9

4.0

12.07

8.57

mg/mmol

2.34

1305

10441

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1203

9139

1.41

22.30

1.4

1.3

1.71

1.66

u/ml

0.05

292

2288

(3012516) Albumin [Mass/volume] in Urine

2028

16743

1.34

22.27

4.0

3.3

62.42

47.31

mg/l

1.96

1315

10529

(36304419) Bacteria [Presence] in Urine

1726

13918

1.35

22.14

3.9

3.4

1.98

175.90

estimate

0.61

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1933

15884

1.34

21.77

2.9

2.7

59.51

65.52

u/l

0.56

1771

14666

(3009508) Creatinine [Moles/volume] in Urine

2057

17104

1.33

21.20

3.9

3.3

6.69

7.01

mmol/l

3.31

1670

14161

(3026782) Osmolality of Urine

1329

10343

1.38

21.16

3.3

3.1

507.36

526.38

mosm/kgh2o

3.04

1167

9052

(40768797) Stomach Pathology biopsy report

914

6666

1.45

21.12

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3791

34473

1.34

20.14

27.7

23.9

13.92

13.89

0.67

3742

33975

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1841

15178

1.32

19.75

6.2

6.0

4.95

3.86

ug/l

0.26

1640

13572

(3007164) IgA [Mass/volume] in Serum or Plasma

1045

7963

1.39

18.58

1.6

1.5

2.63

2.58

g/l

0.24

576

4538

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1405

11259

1.34

18.00

1.9

1.8

12407164.47

26805799.77

pmol/l

0.81

1072

9181

(40760892) CBC W Ordered Manual Differential panel - Blood

1195

9346

1.36

17.99

5.3

4.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1319

10502

1.34

17.58

1.9

1.8

1201.00

1164.83

nmol/l

0.69

950

7878

(3041096) Erythrocytes [Presence] in Urine by Automated

1556

12696

1.32

17.47

4.5

3.9

0.12

0.42

estimate

1.11

559

4110

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1396

11225

1.33

17.36

3.0

3.1

2.46

2.47

mmol/l

2.05

1249

10019

(40761536) Microorganisms panel - Urine sediment

545

3731

1.51

17.12

4.6

4.5

—

(3026008) Bacteria identified in Urine by Culture

2080

17677

1.29

17.11

3.9

3.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1006

7711

1.38

17.10

1.4

1.3

41.20

37.39

iu/ml

0.34

280

2355

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1239

9817

1.34

16.98

2.1

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

140

3.74

16.95

37.1

26.6

103.66

111.90

ug/l

0.43

113

(3026493) Urate [Moles/volume] in Serum or Plasma

1547

12682

1.31

16.61

3.2

2.9

356.01

352.92

umol/l

0.49

1322

10887

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1052

8176

1.36

16.29

2.1

2.0

29.80

29.88

0.15

1027

7946

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2077

17745

1.28

16.08

2.1

1.9

1.30

1.32

mmol/l

0.53

1629

14614

(3044640) Blood type and Crossmatch panel - Blood

1913

16177

1.28

16.08

2.9

2.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

677

4899

1.44

15.99

2.7

2.4

5.56

6.92

ug/l

2.09

575

4180

(3007853) Bacteria identified in Skin by Aerobe culture

770

5705

1.41

15.94

2.1

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2502

21900

1.27

15.76

2.6

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

416

2738

1.56

15.61

2.4

2.5

26.82

24.28

au/ml

0.15

215

(3027945) Reticulocytes/Erythrocytes in Blood

906

6922

1.37

15.57

2.8

2.4

1.77

1.79

0.22

777

6121

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

610

4355

1.45

15.47

4.3

3.4

102.93

91.96

ng/l

1.63

498

3671

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1258

10205

1.30

14.20

1.8

1.7

1.51

1.50

mg/l

0.03

990

8059

(3003458) Phosphate [Moles/volume] in Serum or Plasma

920

7143

1.35

14.13

7.6

5.2

1.07

1.03

mmol/l

2.77

846

6577

(3011397) Hemoglobin [Presence] in Urine by Test strip

1450

11993

1.29

14.09

4.8

4.2

0.32

0.47

0.18

159

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1733

14657

1.27

14.06

3.6

3.2

35.99

37.72

u/l

0.30

1619

13714

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

220

1264

1.77

13.99

1.6

1.5

0.94

12.27

iu/ml

1.08

268

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

203

1140

1.81

13.94

1.8

1.9

12.42

12.32

mg/l

0.05

194

1043

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

376

2491

1.55

13.70

1.3

46.02

58.35

au/ml

0.50

172

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

854

6586

1.35

13.67

3.6

4.3

259.32

249.62

u/l

0.28

804

6186

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

928

7247

1.34

13.67

1.3

10.52

13.83

u/ml

0.71

299

2581

(40768446) Kidney Pathology biopsy report

123

3.60

13.64

2.0

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1536

12843

1.27

13.59

3.9

3.3

0.13

0.06

0.63

448

(3002032) Base excess in Venous blood by calculation

742

5607

1.38

13.51

4.7

3.5

1.64

1.90

mmol/l

1.18

651

4904

(3042936) Bacteria identified in Isolate by Culture

926

7247

1.34

13.42

2.3

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

476

3329

1.47

13.38

2.9

10.81

10.53

g/l

0.48

430

3048

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

233

1381

1.72

13.30

1.3

1.4

5.34

22.52

iu/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

284

1776

1.63

13.22

1.2

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

575

4195

1.42

12.87

1.7

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2512

22310

1.24

12.87

3.1

2.9

—

estimate

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

600

4414

1.40

12.80

2.8

2.5

0.66

0.50

e6/l

0.46

575

4258

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

788

6076

1.35

12.55

9.5

7.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

665

5002

1.38

12.40

2.5

2.6

66.05

65.90

g/l

0.19

611

4500

(3021447) Carbon dioxide [Partial pressure] in Venous blood

752

5775

1.35

12.29

4.7

3.5

5.76

5.82

kpa

1.14

731

5638

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1140

9282

1.29

12.26

3.6

3.2

1.06

1.56

e6/l

0.87

663

5034

(3023520) Reticulocytes [#/volume] in Blood

716

5460

1.36

12.24

2.8

2.5

68.43

67.72

e9/l

0.20

522

4002

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

291

2.49

11.75

2.3

32.37

33.60

iu/ml

0.04

(3048689) Calprotectin [Mass/mass] in Stool

665

5044

1.36

11.74

2.2

2.1

142.82

152.16

ug/g

0.24

495

3967

(3019225) pH of Specimen

688

5252

1.36

11.66

4.9

4.4

7.36

0.31

479

3718

(40758558) Short blood count panel - Blood

1675

14358

1.24

11.55

6.9

6.4

—

(3012544) pH of Venous blood

752

5829

1.34

11.50

4.6

3.5

7.38

0.32

485

3390

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

588

4388

1.38

11.48

4.4

4.0

1.22

1.23

mmol/l

2.15

494

3797

(3024354) Oxygen [Partial pressure] in Venous blood

639

4837

1.36

11.42

4.2

2.9

4.59

4.40

kpa

1.38

618

4715

(3017732) Neutrophils [#/volume] in Blood

728

5627

1.34

11.34

3.1

3.4

5.31

4.79

e9/l

0.35

589

4712

(1761868) Lipid panel - Serum or Plasma

1555

13245

1.25

11.31

4.1

3.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

247

1553

1.62

11.28

1.4

263.47

269.04

ug/g

0.16

148

951

(3023420) DNA double strand Ab [Units/volume] in Serum

270

1735

1.59

11.27

2.2

1.7

10.34

6.84

iu/ml

0.88

404

(3014148) Varicella zoster virus Ab [Titer] in Serum

312

2.39

11.05

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

207

1251

1.68

11.05

2.2

1.5

0.22

0.24

g/l

1.58

197

1177

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1449

12288

1.25

10.88

2.7

2.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

211

1290

1.66

10.78

2.2

1.5

1.16

1.18

g/l

0.37

200

1211

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

403

2851

1.45

10.66

1.8

1.7

1.60

1.59

g/l

0.09

349

2440

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

491

3600

1.40

10.64

4.1

3.6

5.07

5.16

kpa

1.74

463

3398

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1036

8495

1.27

10.32

3.8

3.3

3.06

2.69

e6/l

0.55

552

4240

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

181

1077

1.70

10.26

2.6

2.2

146.54

90.37

ug/min

0.66

600

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

318

2164

1.50

10.25

2.1

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

201

1234

1.65

10.13

1.3

1.2

26.92

31.90

u/ml

0.13

(3009343) pH of Capillary blood

475

3492

1.40

10.13

4.1

3.6

7.42

0.45

394

2880

(3028026) IgM [Mass/volume] in Serum or Plasma

373

2637

1.45

9.91

2.2

1.9

1.49

1.37

g/l

0.24

344

2393

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

900

1.76

9.89

6.4

4.2

1808.42

2466.17

iu/ml

0.13

117

(3036481) Cortisol [Moles/volume] in Serum or Plasma

571

4341

1.35

9.88

2.1

2.3

393.12

387.01

nmol/l

0.24

517

3981

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1080

8943

1.26

9.87

3.3

3.0

0.82

0.81

mmol/l

0.50

990

8332

(3026250) Tacrolimus [Mass/volume] in Blood

120

3.18

9.84

43.4

33.3

7.08

ug/l

0.00

105

(3008898) HLA-B27 [Presence]

163

955

1.73

9.79

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

102

515

2.00

9.79

1.2

59.64

66.81

u/l

0.44

453

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1429

12217

1.23

9.77

5.0

4.9

22.56

22.27

0.32

818

6451

(3000494) Fungus identified in Specimen by Culture

696

5477

1.31

9.48

1.6

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

1451

12456

1.23

9.48

4.7

4.2

85.93

85.59

0.19

1432

12183

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

183

1119

1.66

9.39

1.2

9.38

5.66

u/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

229

1480

1.57

9.37

1.8

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

114

610

1.89

9.25

1.3

1.2

261.12

276.85

u/ml

0.25

362

(3017143) Hepatitis C virus Ab [Presence] in Serum

499

3766

1.36

9.05

1.9

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

188

1170

1.63

9.02

1.3

3.09

6.62

u/ml

1.44

178

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

417

3060

1.39

8.99

3.9

3.5

1.64

2.18

mmol/l

2.25

304

2244

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

292

2007

1.48

8.99

2.0

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

187

1166

1.63

8.91

1.3

1.2

2.43

3.04

u/ml

0.21

114

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1062

8870

1.25

8.90

3.6

3.5

0.80

0.82

ug/l

0.43

785

6269

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

492

3725

1.35

8.74

1.9

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

158

950

1.68

8.68

1.2

188.57

380.00

titre

—

(3020779) Urea [Moles/volume] in Serum or Plasma

635

4995

1.31

8.65

9.8

6.1

12.33

10.96

mmol/l

4.20

606

4748

(3010421) pH of Blood

253

1716

1.50

8.34

4.4

3.8

7.41

0.74

246

1699

(1616796) Gas panel - Central venous blood

193

1234

1.59

8.31

3.7

3.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

282

1961

1.46

8.21

2.9

2.8

24.52

24.89

mmol/l

0.85

275

1929

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

890

1.68

8.15

1.3

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

550

4279

1.32

8.11

4.3

4.0

0.59

0.72

1.08

177

1389

(36660697) Celiac disease serology panel - Serum

435

3271

1.36

8.08

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

554

4325

1.31

7.97

4.3

4.1

0.10

0.12

0.38

167

1288

(46235355) HIV 1 and 2 tests - Meaningful Use set

613

4855

1.30

7.92

1.9

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

124

717

1.75

7.88

1.5

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

352

2569

1.40

7.86

3.5

3.2

4.27

4.39

pmol/l

1.59

309

2241

(3003327) Ova and parasites identified in Stool by Light microscopy

201

1317

1.55

7.80

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

212

1408

1.53

7.74

3.9

2.5

1.94

1.71

mg/l

2.25

186

1249

(3025159) Blasts/Leukocytes in Blood

548

4294

1.31

7.67

4.5

4.3

0.06

0.25

1.19

160

1192

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

470

3605

1.33

7.65

1.6

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

162

1014

1.62

7.65

1.3

1.2

1.14

6.20

u/ml

1.34

(3027273) Bicarbonate [Moles/volume] in Venous blood

364

2684

1.38

7.65

3.8

3.3

25.08

25.23

mmol/l

0.41

349

2607

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1232

10604

1.21

7.57

4.8

4.3

477.66

454.38

ng/l

0.04

1040

9110

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

685

5543

1.27

7.46

3.0

2.6

9.41

9.57

umol/l

0.07

591

4864

(3005322) IgE [Units/volume] in Serum or Plasma

328

2387

1.40

7.46

1.4

1.3

280.44

237.08

u/ml

0.18

304

2178

(3000991) Gas panel - Venous blood

604

4819

1.29

7.37

8.1

7.9

—

(3017181) Myelocytes/Leukocytes in Blood

571

4526

1.29

7.33

4.4

4.1

0.97

0.00

183

1481

(3014111) Lactate [Moles/volume] in Serum or Plasma

631

5067

1.28

7.31

6.3

6.8

1.33

1.37

mmol/l

0.72

615

4958

(3024471) HLA-A [Type]

3.23

7.23

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

385

2896

1.35

7.15

2.7

2.5

—

(3012501) Base excess in Blood by calculation

171

1103

1.57

7.15

4.6

4.5

2.47

2.77

mmol/l

0.70

123

754

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

395

2984

1.35

7.13

5.1

4.0

49.02

46.39

1.26

387

2942

(3013290) Carbon dioxide [Partial pressure] in Blood

171

1104

1.57

7.12

4.6

4.5

5.05

5.01

kpa

0.27

164

1085

(3024932) HLA-DR beta [Type]

3.26

7.09

1.2

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

151

953

1.60

6.93

3.7

3.4

59.60

58.87

0.34

151

953

(3037121) Protein [Mass/volume] in Urine

253

1782

1.44

6.93

3.8

2.9

517.36

387.77

mg/l

0.51

118

723

(3027315) Oxygen [Partial pressure] in Blood

171

1112

1.56

6.91

4.5

8.46

8.32

kpa

0.43

164

1092

(3020876) Protein [Mass/time] in 24 hour Urine

113

662

1.72

6.91

1.9

2.4

1.32

1.16

g/24h

0.23

372

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

136

838

1.64

6.88

1.3

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

724

1.69

6.85

2.9

2.3

279.67

1397.59

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

172

1123

1.55

6.83

1.7

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

831

6941

1.23

6.82

2.0

1.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

2494

1.37

6.80

2.1

2.4

4.20

4.19

g/l

0.09

304

2238

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

2496

1.37

6.77

2.1

2.4

7.50

7.51

g/l

0.02

304

2233

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

2489

1.37

6.74

2.1

2.4

3.55

3.66

g/l

0.72

304

2232

(3002256) Pathology report gross observation

782

6509

1.24

6.62

1.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

272

1958

1.41

6.62

2.5

2.7

—

(3022313) Gas panel - Capillary blood

322

2386

1.37

6.59

4.5

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

552

4417

1.28

6.57

1.8

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

883

7449

1.22

6.57

2.0

1.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

330

2462

1.36

6.48

1.9

1.67

2.13

ug/l

0.41

287

2140

(4146454) Self-monitoring of blood glucose

570

1.75

6.46

3.2

2.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

284

2.05

6.20

1.3

1.2

18.31

24.14

u/l

0.74

236

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

720

5981

1.24

6.20

5.9

5.2

33.76

33.54

0.21

465

3770

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

574

4664

1.26

6.02

2.5

2.4

36.14

50.16

u/l

0.71

479

3925

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

295

2.01

5.98

1.3

1.2

82.66

87.22

u/l

0.19

251

(3011412) CD3 cells [#/volume] in Blood

386

1.88

5.96

2.0

968.60

1129.13

e6/l

1.06

344

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

135

863

1.58

5.93

1.3

1.2

33.23

48.50

u/ml

0.47

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

2.49

5.93

1.1

—

(3000012) Reticulocyte production index

139

895

1.57

5.92

2.5

2.1

0.89

0.88

0.11

619

(3021879) Hepatitis B virus core Ab [Presence] in Serum

333

2528

1.34

5.86

1.6

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

182

1245

1.48

5.86

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

298

2226

1.36

5.83

1.3

—

(3045414) Leukocytes [Presence] in Urine

596

4882

1.25

5.82

2.4

2.2

0.00

0.01

estimate

1.02

901

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.82

5.82

1.3

1.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

481

3847

1.28

5.76

2.9

2.7

56.58

61.10

ml/min/173m2

1.99

213

1717

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

180

1233

1.48

5.76

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

182

1251

1.47

5.73

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

2166

1.36

5.69

2.3

10.15

10.13

g/l

0.02

255

1880

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

217

1544

1.42

5.69

1.5

1.6

19.45

25.42

u/ml

0.57

260

(3022145) Colonoscopy Study observation

649

5383

1.23

5.66

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

1274

11253

1.17

5.62

5.4

4.7

1.02

1.28

kg/l

0.81

924

7633

(3015171) Extractable nuclear Ab [Units/volume] in Serum

227

1632

1.41

5.61

1.4

1.2

2.80

1.15

u/ml

0.48

146

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

205

1451

1.43

5.54

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

433

1.79

5.50

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

433

1.79

5.50

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

433

1.79

5.50

1.4

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

451

3604

1.27

5.45

3.7

3.0

128.05

127.28

g/l

0.31

440

3495

(3004616) Nuclear Ab [Presence] in Serum

562

1.68

5.43

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

156

1053

1.50

5.39

1.5

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

632

1.64

5.39

1.7

1.3

136.81

158.42

au/ml

1.12

176

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

101

621

1.64

5.25

1.1

2.00

9.00

u/ml

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

437

3497

1.27

5.22

7.3

7.5

24.96

24.93

mmol/l

0.06

430

3477

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

250

1855

1.36

5.14

4.7

3.9

24.54

25.05

mmol/l

1.85

223

1656

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.35

5.13

2.7

6.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

195

1389

1.42

5.12

1.5

1.7

—

(3021901) Oxygen saturation in Capillary blood

174

1214

1.45

5.11

2.8

2.9

89.50

88.99

0.50

169

1181

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.01

5.09

1.2

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

2323

1.32

5.02

2.1

2.4

2.89

2.95

g/l

0.43

271

2065

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

295

1.91

4.95

1.2

1.1

—

(40768443) Skin Pathology biopsy report

297

2276

1.32

4.94

1.3

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

191

1366

1.41

4.91

3.0

2.9

7.84

7.83

kpa

0.02

185

1332

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

464

1.71

4.90

2.6

2.2

2.15

1.32

u/field

0.97

244

(3042733) HLA Ab [Presence] in Serum

2.78

4.87

7.0

4.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3575

34146

1.14

4.85

30.5

25.3

330.71

330.93

g/l

0.79

3558

33887

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

298

1.89

4.81

1.4

1.5

6.74

7.17

u/l

0.10

239

(4035726) Immunohistochemistry procedure

550

4564

1.23

4.78

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.01

4.62

1.5

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

179

1281

1.41

4.61

3.9

3.5

8.37

7.55

mmol/l

2.26

174

1250

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

240

1.97

4.58

1.2

1.1

85.22

82.24

—

(3018333) Ribosomal P Ab [Presence] in Serum

291

1.86

4.49

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

161

2.18

4.48

1.3

1.2

0.59

0.51

ratio

0.71

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

183

1326

1.39

4.40

2.5

2.3

3.76

3.63

g/l

0.50

175

1264

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

118

787

1.51

4.39

2.4

1.4

0.84

0.85

nmol/l

0.06

657

(3036489) Thrombin time

222

1662

1.35

4.37

2.1

1.9

21.46

21.16

0.21

202

1513

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

169

1210

1.41

4.36

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

239

1.93

4.28

1.2

1.1

51.00

40.13

mg/l

0.87

204

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

176

1274

1.39

4.27

2.4

2.1

92.01

90.29

0.44

170

1230

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

569

1.59

4.26

1.1

1.51

1.55

g/l

0.53

506

(3007566) Smooth muscle Ab [Titer] in Serum

159

1134

1.41

4.21

1.2

86.00

102.75

titre

0.35

102

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

583

4935

1.20

4.16

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1.79

4.14

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1.79

4.14

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

163

1172

1.40

4.13

1.4

1.3

61.18

60.85

mmol/l

0.04

136

935

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

113

758

1.50

4.12

1.4

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

182

1335

1.38

4.10

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

165

1191

1.40

4.09

2.4

2.3

203.17

207.82

0.25

154

1133

(3004775) Volume in Urine collected for unspecified duration

375

1.72

4.07

2.5

2.1

635.52

640.85

0.05

236

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

276

2155

1.30

4.07

2.3

2.4

0.87

0.91

g/l

0.06

236

1822

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

251

1.88

4.05

2.2

2.1

174.50

216.84

e6/l

0.94

220

(3021788) Differential panel - Synovial fluid

140

983

1.44

4.05

1.6

1.5

—

1.00

—

(3037756) Immunofixation for Serum or Plasma

177

1296

1.38

4.03

1.5

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

247

1903

1.31

4.02

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

121

829

1.47

3.99

1.8

1.9

4.09

4.63

mmol/24h

1.14

107

709

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

360

2913

1.25

3.97

1.4

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

109

734

1.50

3.92

6.6

6.1

12.03

12.74

mg/l

0.95

102

675

(1175426) CD3 cells/Lymphocytes in Blood

313

1.77

3.89

1.8

1.9

74.40

72.36

0.46

292

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

151

1084

1.40

3.88

1.5

1.3

556.43

593.78

mg/l

0.47

145

1030

(40759836) Histone Ab [Presence] in Serum by Immunoblot

321

1.75

3.87

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

157

1137

1.39

3.84

2.0

1.8

4.41

9.59

iu/l

0.43

404

(3006184) Hemoglobin [Mass/volume] in Capillary blood

186

1386

1.35

3.82

2.2

2.3

127.42

125.51

g/l

0.48

145

1087

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

599

5128

1.19

3.78

2.3

2.1

0.21

0.20

g/l

1.10

546

4756

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

160

1167

1.38

3.76

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

160

1167

1.38

3.76

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

532

1.57

3.75

1.3

1.2

5.00

4.93

u/ml

0.02

234

(44790048) Parainfluenza type 2 nucleic acid detection

604

1.53

3.74

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

604

1.53

3.74

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

604

1.53

3.74

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

604

1.53

3.74

1.4

—

(3049717) Cytology report of Urine Cyto stain

277

2193

1.28

3.69

2.9

2.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

296

1.76

3.69

1.7

1.9

16.52

15.99

0.11

285

(3016650) Hepatitis A virus Ab [Presence] in Serum

616

1.52

3.64

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.48

3.62

3.8

3.3

5.87

8.09

mg/l

1.33

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

247

1.83

3.61

2.3

2.0

413.63

529.51

e6/l

0.83

203

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

483

1.58

3.58

1.6

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

452

1.60

3.57

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

182

1368

1.34

3.56

1.6

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.77

3.55

3.7

3.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.05

3.52

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

199

1518

1.32

3.52

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

1113

1.38

3.51

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

264

1.79

3.51

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.01

3.49

3.2

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1.72

3.49

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

236

1.83

3.46

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.89

3.46

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

319

1.70

3.40

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

366

3022

1.23

3.40

2.4

2.2

12.66

12.29

nmol/l

0.35

325

2657

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.39

3.38

2.4

1.9

9.13

8.85

mg/l

0.07

(3003694) ABO and Rh group [Type] in Blood

1289

11761

1.13

3.37

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

359

1.65

3.33

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

516

1.54

3.33

1.6

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.68

3.31

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

269

1.75

3.31

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.92

3.29

1.2

109.07

93.14

ng/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1613

1.30

3.29

2.4

0.00

g/l

-0.00

192

1501

(3023183) Ammonium ion [Moles/volume] in Plasma

143

1050

1.37

3.27

2.9

2.4

32.15

33.68

umol/l

0.35

129

932

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

256

2041

1.27

3.26

2.9

2.8

0.34

0.36

iu/ml

0.30

142

1125

(3016750) Collection duration of Urine

263

1.76

3.26

2.1

2.0

512.97

494.25

min

0.50

189

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

228

1799

1.28

3.17

2.3

2.4

0.07

0.03

g/l

0.45

206

1606

(3004716) Salmonella sp identified in Stool by Organism specific culture

212

1658

1.29

3.16

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

251

1.76

3.15

1.6

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

251

1.76

3.15

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

251

1.76

3.15

1.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

251

1.76

3.15

1.6

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

220

1730

1.28

3.14

2.3

2.4

0.00

g/l

0.50

194

1507

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.61

3.11

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

300

2452

1.24

3.09

2.6

2.2

0.04

0.38

estimate

0.46

698

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

128

936

1.38

3.03

1.6

1.4

8.76

33.89

e6/l

1.90

695

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

307

1.67

3.03

2.2

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

129

945

1.37

3.02

1.7

1.4

873.44

1056.80

e6/l

0.12

108

750

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

377

1.60

3.02

1.3

1.2

113.03

108.54

pmol/l

0.19

377

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

140

2.01

2.99

1.4

1.2

18.98

10.96

pmol/l

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

154

1.95

2.98

1.5

2.3

197427.33

58766.13

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

130

956

1.37

2.98

1.4

1.3

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

197

1.83

2.97

1.4

1.5

2.34

2.96

0.22

171

(3044927) Protein electrophoresis panel - Urine

605

1.46

2.95

1.3

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

141

1.99

2.94

1.1

1.3

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

205

1.81

2.94

1.2

63.83

66.32

—

(3022621) pH of Urine by Test strip

453

3876

1.18

2.92

3.3

3.1

6.04

6.08

0.40

325

2741

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

213

1.79

2.91

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

683

1.43

2.88

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

617

1.45

2.87

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

667

1.43

2.86

1.3

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

174

1346

1.30

2.85

1.6

9745.59

14510.06

e6/l

1.80

133

931

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

229

1835

1.26

2.84

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

306

1.64

2.82

1.7

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

283

1.67

2.81

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

283

1.67

2.81

1.3

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

185

1446

1.29

2.81

5.4

4.6

—

(3042631) Mycobacterium sp identified in Specimen

107

772

1.39

2.78

2.9

2.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

655

1.43

2.77

1.6

1.5

0.67

0.83

g/l

0.56

509

(40768441) Liver Pathology biopsy report

308

1.63

2.75

1.8

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

707

1.41

2.73

2.3

2.1

22.41

25.13

mg/l

0.30

238

(3033099) Centromere Ab [Titer] in Serum

2.18

2.66

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

677

1.41

2.66

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

652

1.42

2.66

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

753

6743

1.14

2.65

6.6

6.8

0.86

1.07

mmol/l

0.79

621

5508

(3016018) Differential panel - Cerebral spinal fluid

471

1.49

2.64

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

2.13

2.64

7.0

6.6

9.10

8.29

mmol/l

0.81

(21494814) CD8 cells/Lymphocytes in Specimen

176

1.82

2.63

1.6

2.0

31.47

31.17

0.03

176

(3034860) Kappa light chains.free [Mass/volume] in Serum

262

2152

1.23

2.63

2.4

3.3

59.58

82.81

mg/l

0.42

211

1821

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

130

978

1.34

2.62

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

473

1.49

2.60

1.4

1.5

27.36

28.69

0.09

291

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

971

1.34

2.59

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

121

902

1.35

2.59

1.1

2.96

3.92

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

507

1.47

2.57

3.7

2.8

—

(3018133) Calcium [Moles/volume] in Urine

2.36

2.55

1.6

3.44

2.98

mmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

494

1.46

2.49

1.6

1.7

25.20

25.84

u/ml

0.03

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.98

2.48

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.32

2.48

1.4

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.20

2.47

2.4

1.7

0.08

1.33

e9/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

654

1.40

2.46

1.3

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

130

1.93

2.44

1.3

1.5

14.82

15.61

pmol/l

0.37

105

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.46

2.44

2.9

2.8

0.36

0.49

u/field

0.26

(3020961) Endomysium IgA Ab [Titer] in Serum

211

1709

1.24

2.43

1.1

136.43

155.94

titre

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

656

1.39

2.42

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

665

1.39

2.41

1.5

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.90

2.41

2.2

1.8

—

(3004809) Band form neutrophils/Leukocytes in Blood

126

957

1.32

2.41

3.5

3.7

1.42

1.74

0.47

110

832

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

204

1.72

2.40

1.3

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

259

2150

1.22

2.37

2.4

3.3

43.45

51.91

mg/l

0.47

209

1820

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

110

822

1.35

2.35

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.15

2.34

1.4

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

235

1935

1.22

2.34

2.4

3.2

4.86

5.42

ratio

0.07

136

1133

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

140

1.86

2.31

1.3

1.2

22.40

21.25

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

754

6812

1.12

2.31

6.7

6.9

5.00

5.10

kpa

2.34

727

6532

(3024928) Oxygen saturation in Venous blood

170

1352

1.27

2.31

3.4

2.5

61.39

59.25

0.60

162

1311

(3027801) Oxygen [Partial pressure] in Arterial blood

753

6809

1.12

2.27

6.7

6.8

11.63

12.02

kpa

1.44

730

6523

(3018405) Lactate [Moles/volume] in Arterial blood

227

1869

1.22

2.27

3.8

3.6

1.37

1.39

mmol/l

0.08

220

1837

(3013139) Helicobacter pylori Ag [Presence] in Stool

365

3142

1.17

2.25

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

685

6164

1.13

2.25

3.7

4.1

24.23

23.85

ug/l

0.01

556

5129

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

556

1.41

2.24

1.2

2.76

4.10

u/ml

0.57

187

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

310

1.55

2.24

1.1

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.56

2.21

7.6

5.6

632.40

338.33

umol/l

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

400

1.48

2.20

1.5

1.3

0.38

0.45

g/l

0.84

294

(3028192) IgG subclass 2 [Mass/volume] in Serum

400

1.48

2.20

1.5

1.3

2.69

2.91

g/l

0.55

295

(3027135) IgG subclass 1 [Mass/volume] in Serum

400

1.48

2.20

1.5

1.3

7.24

7.01

g/l

0.21

294

(44816559) Phosphatidylethanol [Mass/volume] in Blood

178

1433

1.25

2.20

1.6

0.33

0.32

mg/l

0.08

623

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

3.34

2.18

1.6

1.8

—

(3028433) Virus identified in Specimen by Culture

136

1.84

2.17

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

518

1.41

2.16

1.3

1.2

36.58

52.70

u/ml

—

(3017704) Immunofixation for Urine

297

1.55

2.16

1.2

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.17

2.14

1.1

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

125

968

1.30

2.12

1.7

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

580

5186

1.13

2.12

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.37

2.12

1.2

91.23

101.69

0.39

(3034274) Bile acid [Moles/volume] in Serum --fasting

236

1.61

2.10

2.2

1.6

9.72

9.17

umol/l

0.06

158

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

236

1.61

2.10

1.2

—

(3011985) Renin [Units/volume] in Plasma

657

1.36

2.10

1.3

1.4

38.64

59.71

mu/l

0.91

582

(3019174) dRVVT (LA screen)

3.20

2.09

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

160

1.75

2.09

1.1

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

153

1.77

2.07

1.1

1.3

—

0.45

—

(4062490) Immunoglobulin typing, IgG

398

1.46

2.06

1.5

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

117

902

1.30

2.06

1.5

29.76

31.30

g/l

0.81

108

803

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

341

1.50

2.06

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

668

1.35

2.05

1.8

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

176

1.71

2.05

1.1

1.07

1.18

u/l

0.64

(21494890) Protein electrophoresis panel - 24 hour Urine

600

1.37

2.05

1.3

2.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

199

1637

1.22

2.04

1.8

1.5

—

(3006270) Folate [Moles/volume] in Blood

458

1.42

2.02

1.4

1.2

316.90

334.73

nmol/l

0.33

356

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

162

1.73

2.01

2.4

2.6

0.62

mmol/l

0.07

162

(3044009) aPTT.lupus sensitive (LA screen)

3.08

2.01

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.50

2.01

1.2

1.5

—

(21494755) Public health laboratory ask at order entry panel

137

1719

0.79

1.98

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

248

1.58

1.97

1.6

1.9

334.13

301.83

mu/l

0.31

200

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

461

1.42

1.96

1.6

1.4

—

(3019977) pH of Arterial blood

745

6797

1.11

1.94

6.8

6.9

7.42

1.32

430

3751

(37208534) Antinuclear antibody arbitrary concentration in serum

120

1.84

1.92

1.0

—

(3016502) Oxygen saturation in Arterial blood

667

6052

1.12

1.92

6.8

7.1

94.73

95.34

1.15

652

5824

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

250

1.56

1.92

2.3

1.9

5.07

2.65

u/field

0.73

170

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

154

1242

1.25

1.91

1.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

549

1.37

1.89

1.1

44.36

23.66

au/ml

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

618

1.35

1.88

1.5

57.47

61.73

0.40

384

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

181

1.66

1.88

1.3

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

193

1599

1.21

1.87

3.5

3.4

0.80

0.81

nmol/l

0.10

147

1283

(3005532) Lymphocytes/Leukocytes in Pleural fluid

228

1.58

1.87

1.3

1.5

67.26

67.46

0.01

192

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

189

1.64

1.87

1.7

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

189

1.64

1.87

1.7

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

136

1.77

1.86

1.3

200.29

119.05

nmol/l

0.85

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

419

3702

1.14

1.86

1.6

1.7

1.52

1.53

0.16

351

3148

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

646

1.34

1.85

1.1

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

707

1.32

1.84

1.5

1.4

12.03

11.27

u/l

0.15

572

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

285

1.51

1.84

1.3

3.93

1.40

u/ml

0.62

166

(3014271) Vancomycin [Susceptibility]

334

1.47

1.83

3.3

3.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

137

1.76

1.82

1.3

1.5

58.82

386.70

nmol/24h

0.91

137

(3043410) Blood group antigens tested for on Red Blood Cells

137

1.76

1.82

4.2

2.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.17

1.82

1.2

1.0

—

(4268621) Lupus anticoagulant assay

376

1.44

1.82

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

202

1687

1.21

1.81

2.1

1.8

—

(3000330) Specific gravity of Urine by Test strip

322

2800

1.16

1.80

4.5

3.8

1.02

ratio

0.23

306

2533

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

287

1.50

1.79

1.6

1.5

0.24

0.27

nmol/l

0.19

209

(4195642) Thrombophilia screening test

479

1.38

1.77

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

192

1.62

1.77

1.7

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

281

2422

1.17

1.76

1.2

105.08

124.91

u/ml

0.46

857

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.50

1.73

1.0

1.1

6.28

6.22

mmol/l

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

132

1.75

1.73

2.0

1.8

31.87

31.63

0.02

121

(3034426) Prothrombin time (PT)

110

1.82

1.72

1.2

1.3

27.60

28.30

0.31

110

(3016228) CD19 cells/cells in Blood

178

1.63

1.72

1.6

1.9

5.97

7.52

0.40

169

(3028308) Erythrocytes [#/volume] in Pleural fluid

689

1.31

1.72

1.5

1.4

28776.30

60305.95

e6/l

1.44

389

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

381

1.42

1.71

1.0

1.1

2.36

3.01

u/ml

0.23

187

(3052851) Hemolysis interference index of Serum or Plasma

180

1497

1.21

1.70

3.2

3.6

1.09

1.89

index

1.83

753

(3008152) Bicarbonate [Moles/volume] in Arterial blood

410

3643

1.14

1.70

6.8

6.3

24.42

24.62

mmol/l

0.50

395

3491

(3021387) Prolactin [Units/volume] in Serum or Plasma

717

1.30

1.69

1.8

468.98

302.66

mu/l

0.88

659

(4094501) Cardiovascular stress test using bicycle ergometer

149

1218

1.23

1.68

1.1

—

(3025130) Human papilloma virus identified in Specimen

383

1.41

1.67

1.9

1.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

284

1.48

1.66

1.4

1.5

13.80

13.94

umol/l

0.04

262

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.86

1.65

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

555

5031

1.12

1.65

3.4

3.1

234.96

227.76

ng/l

0.15

510

4629

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

384

1.41

1.65

1.1

1.2

95.81

95.11

0.06

358

(3024263) Appearance of Synovial fluid

252

1.51

1.65

1.3

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

135

1097

1.24

1.62

3.8

3.7

27.50

29.01

mg/l

0.21

788

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.84

1.61

1.4

1.6

9.44

8.63

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.84

1.61

1.1

—

(3020491) Glucose [Moles/volume] in Blood

312

1.45

1.58

1.8

2.4

7.43

6.86

mmol/l

0.60

214

(3010144) Erythrocytes [#/volume] in Synovial fluid

525

1.34

1.57

1.4

88695.98

128808.78

e6/l

0.26

346

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

380

1.40

1.56

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

114

1.76

1.56

1.6

5973.33

3570.91

titre

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

483

1.35

1.55

1.1

1.2

122.32

114.07

1.19

428

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

148

1223

1.22

1.53

3.2

296.15

772.87

u/ml

1.10

135

1116

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

130

1.70

1.52

1.2

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.59

1.51

1.4

1.7

—

(3004451) EKG impression Narrative

349

1.41

1.51

1.1

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

108

1.76

1.50

2.7

2.3

7.59

7.51

mmol/l

0.03

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

714

1.28

1.49

1.6

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

513

1.33

1.48

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

609

1.30

1.48

1.3

266.53

292.50

pmol/l

0.43

507

(3040151) Glucose [Moles/volume] in Capillary blood

680

1.28

1.47

9.0

5.6

7.98

7.12

mmol/l

1.22

565

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.22

1.46

1.8

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

220

1.50

1.43

1.2

1.1

148.15

136.08

nmol/l

0.51

220

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

181

1537

1.18

1.42

2.1

1.7

—

(40768795) Lymph node Pathology biopsy report

483

1.33

1.40

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

329

1.40

1.0

1.1

1.38

1.57

u/ml

0.06

175

(3035880) pH of Pleural fluid

329

1.40

1.4

1.3

7.41

0.01

220

(40762814) Titanium [Mass/volume] in Blood

1.77

1.38

2.4

2.3

2.83

3.34

ug/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.08

1.38

1.2

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

125

1029

1.22

1.37

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.20

1.36

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

281

1.43

1.35

1.2

1.4

1.30

1.06

promille

0.48

222

(3008295) Osmolality of Serum or Plasma

618

1.28

1.35

1.3

277.26

275.46

mosm/kgh2o

0.20

446

(3008401) Mugwort IgE Ab [Units/volume] in Serum

375

1.36

1.33

1.0

1.1

1.18

1.10

u/ml

0.05

153

(46235168) Fasting glucose [Moles/volume] in Blood

2.13

1.33

2.6

5.4

7.78

8.10

mmol/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

380

3420

1.12

1.33

8.0

8.5

24.13

24.35

mmol/l

0.77

369

3325

(3020874) Milk IgE Ab [Units/volume] in Serum

128

1.64

1.33

1.1

1.0

0.54

u/ml

0.00

(3038177) Helicobacter pylori Ab [Presence] in Serum

550

1.29

1.31

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

113

1.68

1.31

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

168

1.55

1.31

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.35

1.29

1.1

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

369

1.36

1.29

1.9

1.7

106.19

107.59

ng/l

0.03

369

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.78

1.28

4.6

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

276

1.42

1.28

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

227

1.46

1.26

1.1

4.2

66.00

69.36

mg/l

0.11

153

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.74

1.24

1.0

0.16

0.28

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

512

1.29

1.22

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

601

1.27

1.22

4.4

4.8

312.03

341.08

umol/l

0.87

520

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

664

1.25

1.21

1.1

—

1.08

—

(3034891) Synovial lining cells/cells in Synovial fluid

246

1.43

1.20

1.6

1.5

2.00

3.70

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

205

1.47

1.19

1.1

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

775

1.23

1.17

1.6

1.5

991.72

3350.60

e6/l

1.33

539

(4281824) Cell count and differential, peritoneal fluid

589

0.74

1.16

1.4

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1.42

1.15

1.1

1.7

38.67

39.75

g/l

0.29

240

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

110

1.64

1.15

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

466

1.29

1.12

1.1

1.85

1.41

u/ml

0.17

256

(3052592) Norovirus Ag [Presence] in Stool

112

0.45

1.12

1.0

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.90

1.12

1.0

1.2

—

78.84

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

225

1.42

1.11

1.7

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

285

1.37

1.10

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

628

0.76

1.09

1.3

1.2

0.48

0.63

ratio

3.04

101

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

112

1.61

1.08

1.3

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.19

1.08

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

3.50

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.19

1.08

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.87

1.07

1.0

1.2

—

74.65

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

559

1.26

1.07

1.0

1.1

16.52

1721.45

iu/ml

0.71

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.12

1.05

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

228

1.41

1.05

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

228

1.41

1.05

1.4

1.3

1.18

1.24

nmol/l

0.11

167

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.71

1.05

1.1

320.00

861.90

titre

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

599

5588

1.08

1.04

7.6

117.87

119.74

g/l

1.51

588

5454

(3002079) Sodium [Moles/time] in 24 hour Urine

162

1.48

1.04

1.3

1.2

118.83

162.37

mmol/24h

2.46

162

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

154

1.50

1.03

1.1

—

(4024509) Urine culture

283

2550

1.12

1.02

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

179

1.45

1.02

1.3

2.1

50.85

120.43

umol/l

1.85

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

1.58

1.02

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

255

1.38

1.02

2.2

2.5

37.25

37.37

0.01

147

(3042111) Morphology [Interpretation] in Bone marrow Narrative

118

1001

1.18

1.01

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

708

1.22

1.01

1.3

0.30

0.26

nmol/l

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

239

1.38

1.00

1.8

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

1.53

0.99

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.80

0.98

9.3

12.8

5.86

5.08

mmol/l

0.43

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.97

0.0

1.7

—

0.17

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

100

840

1.19

0.97

1.4

37.54

30.68

iu/l

1.08

714

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

0.96

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.85

0.96

1.2

1.5

50.10

46.56

umol/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

1.55

0.96

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

116

1.55

0.96

1.0

0.63

2.32

u/ml

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

108

1.58

0.96

2.8

2.0

1.11

1.04

ug/l

0.03

101

(3006442) Creatine [Moles/volume] in Serum or Plasma

277

1.34

0.93

1.7

1.6

96.32

87.55

umol/l

0.32

277

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

243

1.36

0.92

2.5

3.2

0.71

1.35

2.71

243

(4133840) Spirometry

1.67

0.91

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

235

1.36

0.91

5.1

7.1

5.38

276.07

ug/l

1.11

145

(3025018) Bordetella pertussis Ab [Titer] in Serum

201

1.40

0.91

1.1

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.07

0.89

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.69

0.88

1.2

17.53

21.82

u/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.91

0.88

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

556

1.23

0.88

4.0

4.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

693

1.20

0.88

1.6

1.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

237

1.35

0.87

3.4

3.0

193.47

206.17

u/l

0.86

232

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

103

1.56

0.87

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.86

0.87

5.8

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

422

1.26

0.87

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

458

1.25

0.87

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

0.87

1.5

1.2

—

(3025577) Chromium [Mass/volume] in Blood

360

1.28

0.86

2.0

2.2

1.70

2.08

ug/l

0.61

305

(3007930) Methemoglobin/Hemoglobin.total in Blood

274

2494

1.10

0.86

5.2

4.7

0.86

0.14

261

2364

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

178

1.41

0.86

1.1

163.22

454.91

ng/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

650

1.20

0.85

1.3

1.2

163.37

214.85

miu/ml

0.57

226

(3044007) Cell count panel - Peritoneal fluid

179

0.61

0.84

2.5

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.59

0.84

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

343

0.73

0.83

1.5

1.6

1034.90

965.06

mu/l

0.19

282

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

129

1.47

0.83

1.2

1.4

11.74

10.80

mm/h

0.11

129

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

579

1.21

0.83

1.2

1.3

—

nmol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

1.44

0.82

1.1

1500.62

1576.10

miu/ml

0.14

146

(3019230) Fractional oxyhemoglobin in Venous blood

131

1148

1.14

0.79

3.3

2.2

61.40

60.16

0.26

131

1143

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

776

1.18

0.78

3.5

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

357

1.26

0.78

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.53

0.78

1.3

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.62

0.78

1.1

1.2

66.86

111.50

ug/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

420

1.24

0.78

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

121

1058

1.15

0.76

1.6

1.7

2.84

4.55

mg/l

1.77

806

(3005570) Glucose [Moles/volume] in Urine

530

1.21

0.76

2.5

2.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

288

1.29

0.75

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

288

1.29

0.75

1.1

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

468

1.22

0.74

1.1

2.14

3.20

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.08

0.74

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

423

1.23

0.74

1.1

—

(3017569) Oxygen content in Arterial blood

360

1.25

0.74

2.0

14.53

15.95

2.19

360

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

293

2700

1.09

0.74

5.0

4.6

1.53

1.55

0.21

282

2562

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

223

2448

0.91

0.74

4.5

4.3

73.02

89.87

u/ml

0.27

216

2347

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

289

1.28

0.73

5.2

3.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.80

0.72

1.3

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.71

0.70

7.4

4.1

—

(3045788) Cell count panel - Pleural fluid

638

1.18

0.69

1.6

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

123

1087

1.13

0.68

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

346

1.24

0.68

1.6

1.9

9.13

8.07

mmol/l

0.72

346

(1002224) Polysomnography panel

149

1333

1.12

0.68

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.53

0.68

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

117

0.60

0.67

1.6

41.71

50.20

ug/l

—

117

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

365

1.23

0.67

1.0

670.11

722.05

ng/l

0.39

228

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

365

1.23

0.67

1.0

317.85

322.18

ng/l

0.04

237

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

420

1.22

0.66

1.5

—

(3027944) Amphetamines [Presence] in Urine

539

0.81

0.66

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

366

1.23

0.66

1.0

39.32

42.44

ng/l

0.22

234

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.61

0.65

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

377

1.22

0.64

4.3

2.9

32.81

32.71

mg/l

0.00

282

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

424

1.20

0.62

1.1

1.83

1.84

eliau/ml

—

129

(3028300) Cannabinoids [Presence] in Urine

545

0.82

0.62

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

545

0.82

0.62

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.29

0.61

1.3

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.67

0.61

1.6

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

105

1.43

0.60

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

105

1.43

0.60

1.1

0.61

0.68

umol/24h

—

(3022689) Creatine [Moles/volume] in Urine

122

1.39

0.60

1.4

5.32

6.94

mmol/l

1.51

122

(3027008) Opiates [Presence] in Urine

542

0.83

0.59

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.54

0.59

1.0

1.2

1.80

umol/24h

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.1

—

34.91

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

263

1.26

0.59

1.0

1.1

2.46

3.36

u/ml

0.19

117

(44806420) Estimation of glomerular filtration rate

372

1.21

0.59

2.7

2.6

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

1.3

—

193.33

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.58

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

622

1.16

0.58

1.3

0.20

0.22

nmol/l

0.41

503

(3023419) Bacteria identified in Sputum by Culture

698

1.15

0.57

3.1

2.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.67

0.56

2.3

1.6

1.13

1.47

umol/l

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

167

1.32

0.56

1.1

1.4

69.06

58.53

0.77

144

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

700

0.86

0.56

1.3

1.2

1.53

g/l

0.06

700

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.58

0.56

1.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

578

1.16

0.55

3.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

124

1.37

0.55

1.5

1.4

0.10

0.33

mmol/l

—

(3026480) Teichoate Ab [Titer] in Serum

1.62

0.55

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

107

1.40

0.55

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

177

1.30

0.54

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

303

1.22

0.54

1.5

1.3

26.90

33.92

u/l

0.55

249

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

249

1.25

0.53

1.4

1.5

6.03

7.24

u/l

0.53

211

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

115

1034

1.11

0.53

1.2

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

109

1.38

0.50

2.2

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

242

1.24

0.50

1.0

1.1

0.21

0.26

u/ml

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.46

0.50

15.2

7.9

0.45

0.40

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

156

0.70

0.49

2.5

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

1.34

0.49

2.4

2.1

505.35

332.12

ug/l

0.12

127

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.56

0.49

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.56

0.49

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.56

0.49

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

428

1.17

0.48

1.2

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

190

1.26

0.47

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

1.35

0.46

2.1

1.3

—

(3016879) Cocaine [Presence] in Urine

505

0.85

0.46

1.8

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

421

1.17

0.45

1.2

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

347

1.18

0.45

1.6

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.40

0.45

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

283

1.20

0.44

1.1

0.10

13.06

nmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

274

1.21

0.44

2.7

1.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.37

0.44

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

226

2119

1.07

0.44

2.8

3.2

1025.83

2062.65

u/ml

0.64

195

1821

(3032057) Clostridioides difficile [Presence] in Stool

113

1.33

0.42

1.6

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

1.21

0.42

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.56

0.42

1.2

1.1

—

248.25

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

965

1.10

0.42

1.3

79.71

38.33

u/l

0.54

840

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.38

0.41

1.3

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.34

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

4.8

—

102.00

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.02

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

3.56

—

(3017354) Segmented neutrophils/Leukocytes in Blood

614

1.13

0.41

4.2

3.8

62.49

58.02

1.11

509

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.40

0.0

1.1

—

18.62

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

213

1.22

0.40

1.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

186

1.24

0.40

1.3

1.4

182.83

202.01

pmol/l

0.14

186

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

436

1.15

0.40

1.3

1.58

1.60

nmol/l

0.03

388

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

150

1.27

0.40

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.52

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.17

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

571

0.87

0.39

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.43

0.39

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.04

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.01

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.35

0.37

2.4

4.1

48.25

60.56

u/l

0.26

(3039000) Anion gap in Blood by calculation

108

1175

0.92

0.37

6.5

6.2

11.36

11.37

mmol/l

0.01

1054

(3018572) Chloride [Moles/volume] in Blood

108

1175

0.92

0.37

6.5

6.2

104.70

104.92

mmol/l

0.21

1054

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

336

1.16

0.37

1.6

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

1.29

0.37

1.9

1.6

8.94

9.61

ug/l

0.25

116

(3023410) Appearance of Cerebral spinal fluid

393

1.15

0.36

2.2

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

564

1.12

0.35

1.3

1.6

20.70

27.67

ng/l

1.55

564

(1001926) Buprenorphine [Presence] in Urine by Screen method

417

0.86

0.35

1.9

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.43

0.35

1.0

—

(4015189) Microbial culture of sputum

153

1.24

0.35

1.6

2.3

—

(3020650) Glucose [Presence] in Urine

144

1.25

0.35

2.8

1.9

0.00

0.04

estimate

0.80

144

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.40

0.35

1.0

0.28

2.70

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

127

1.26

0.33

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.67

0.33

1.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

146

1.23

0.32

1.4

1.6

0.48

0.39

ug/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

263

0.84

0.32

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

332

1.15

0.32

4.3

5.8

388.00

89.55

u/ml

—

109

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

475

1.12

0.31

1.6

1.5

—

(3047189) Immunofixation for 24 hour Urine

286

1.15

0.31

1.4

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

609

1.10

0.30

1.6

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

142

0.77

0.30

12.9

14.4

804.36

815.98

nmol/l

0.03

137

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

185

0.81

0.29

1.4

1.5

0.88

0.96

ratio

—

116

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

185

0.81

0.29

1.4

1.5

1.19

1.15

ratio

—

116

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

185

0.81

0.29

1.4

1.5

0.86

1.10

ratio

—

116

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

204

2144

0.95

0.29

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

184

0.81

0.28

1.4

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

534

0.90

0.28

3.8

3.4

17.00

12.20

index

0.95

268

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

251

1.16

0.28

2.6

2.2

67.33

117.16

ug/min

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

289

1.14

0.28

1.0

1.1

5.29

2.35

u/ml

0.37

146

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

242

1.16

0.28

1.8

1.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.27

0.27

1.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

240

2505

0.96

0.27

2.1

3.28

3.43

ratio

1.34

199

2013

(3050129) First trimester maternal screen panel - Serum or Plasma

225

0.84

0.26

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

376

1.12

0.26

1.6

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

149

0.80

0.25

1.4

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.25

0.25

1.1

1.3

10.71

450855.02

nmol/l

—

(21494434) Karyotype in Bone marrow

492

1.10

0.25

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.22

0.25

6.2

7.0

9.09

10.34

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

151

1.19

0.25

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

151

1.19

0.25

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

151

1.19

0.25

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

151

1.19

0.25

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.25

0.24

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

427

1.10

0.23

3.5

2.9

45.51

27.55

mg/l

0.44

315

(3006462) Nitrate [Presence] in Urine

218

1.15

0.23

3.6

3.9

—

(40762887) Creatinine [Moles/volume] in Blood

1.19

0.21

1.0

1.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

8.87

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

80.64

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.16

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

643

1.07

0.21

3.6

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.21

2.6

6.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.16

0.21

1.4

1.1

0.03

u/ml

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

155

0.84

0.20

1.4

1.6

—

(3047181) Lactate [Moles/volume] in Blood

173

1661

1.04

0.20

5.3

5.5

1.32

1.36

mmol/l

0.28

148

1483

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.20

0.19

3.2

2.1

12.93

18.52

umol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

481

1.08

0.19

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

375

1.09

0.19

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.22

0.19

2.0

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.15

0.19

1.0

1.1

33.28

45.38

iu/ml

—

(3002619) Bacteria identified in Specimen by Culture

118

1.19

0.19

1.5

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

335

3265

1.03

0.18

9.3

8.9

15.70

15.79

0.29

324

3153

(40768793) Breast Pathology biopsy report

124

1186

1.05

0.18

1.3

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

119

1.18

0.17

1.4

1.1

—

(4211845) Urine protein measurement

234

1.11

0.16

3.6

3.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

173

1791

0.96

0.16

1.8

3.14

3.43

mmol/l

3.23

125

1288

(40765096) Chromosome analysis panel by Banding

162

0.86

0.16

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.20

0.16

5.5

6.6

5.45

5.16

kpa

0.13

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

691

1.06

0.16

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

111

1.17

0.15

2.4

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.18

0.14

1.5

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.16

0.11

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

740

0.96

0.11

1.4

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

942

0.97

0.10

1.3

1.5

287.66

220.00

pmol/l

0.24

912

(3039443) Prostate specific Ag panel - Serum or Plasma

565

1.04

0.09

1.4

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.14

0.08

2.7

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.06

0.08

3.3

2.3

0.73

0.63

ug/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.84

0.07

1.0

1.1

—

0.32

—

(4198724) Urine methamphetamine measurement

0.83

0.07

1.0

1.5

—

(40758292) HTLV I+II Ab panel - Serum

0.82

0.07

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

176

1.08

0.07

2.8

2.5

9.76

10.27

kpa

0.41

176

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

176

1.08

0.07

2.8

2.5

4.78

4.89

kpa

0.18

176

(3014891) Appearance of Pleural fluid

1.06

0.07

1.6

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

163

0.92

0.07

1.4

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.89

0.06

1.4

1.3

—

(40757373) Influenza virus identified in Isolate

104

0.87

0.06

1.7

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

162

0.93

0.06

1.2

—

(4034850) Laboratory test

143

1452

0.98

0.05

17.0

11.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

159

1.07

0.05

1.1

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.09

0.05

1.4

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

199

1.06

0.04

1.9

2.0

509.92

7420.90

e6/l

0.84

134

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

437

1.03

0.04

1.1

1.3

7.40

7.82

mmol/l

0.39

365

(3028707) Methadone [Presence] in Urine by Screen method

241

0.95

0.04

2.3

2.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

429

1.03

0.03

1.5

2.0

3593.06

3697.68

u/l

0.01

171

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

1.08

0.03

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

109

1078

1.01

0.02

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

113

1.06

0.01

1.3

1.2

2.22

1.59

mmol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

373

1.02

0.01

2.5

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

366

0.98

0.00

2.6

2.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

178

1.01

0.00

1.1

1.2

34.20

39.93

g/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

195

1.03

0.00

1.4

1.3

187.46

236.43

ug/l

0.08

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

177

1.02

0.00

1.8

11148.82

32195.27

e6/l

0.85

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

101

0.99

0.00

1.2

1.3

1.17

mmol/l

—

101

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.95

0.00

1.1

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.01

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.01

0.00

1.4

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

342.78

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.03

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

2.47

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.2

—

1.40

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

17.48

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

292.20

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2781.80

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(4212803) Bone marrow aspirate examination

0.91

-0.00

1.6

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint MACULA_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
MACULA_NAS	0.835 [0.77, 0.9]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.321

During the follow-up period (1.1.1998 — 31.12.2019), 5005 out of 18044 females with MACULA_NAS died.

Males

Parameter	HR [95% CI]	p-value
MACULA_NAS	0.831 [0.76, 0.91]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 3981 out of 12716 males with MACULA_NAS died.

Mortality risk

Mortality risk for people of age

years, who have MACULA_NAS.

N-year risk	Females	Males
1	0.082%	0.134%
5	0.476%	0.925%
10	1.182%	2.498%
15	2.459%	4.884%
20	4.356%	8.585%

Relationships between endpoints

↥

Index endpoint: MACULA_NAS – Degenerative macular diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Degenerative macular diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints